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Concussion, microvascular injury, and early
tauopathy in young athletes after impact head
injury and an impact concussion mouse model
Chad A. Tagge,1,2,* Andrew M. Fisher,1,2,* Olga V. Minaeva,1,2,3,* Amanda GaudreauBalderrama,1,2 Juliet A. Moncaster,1,3,4 Xiao-Lei Zhang,5 Mark W. Wojnarowicz,1,4
Noel Casey,1,6 Haiyan Lu,7 Olga N. Kokiko-Cochran,7,† Sudad Saman,8 Maria Ericsson,9
Kristen D. Onos,10 Ronel Veksler,11 Vladimir V. Senatorov, Jr,12 Asami Kondo,13
Xiao Z. Zhou,13 Omid Miry,5 Linnea R. Vose,5 Katisha R. Gopaul,5 Chirag Upreti,5
Christopher J. Nowinski,4,14 Robert C. Cantu,4,14,15 Victor E. Alvarez,14,16 Audrey
M. Hildebrandt,16 Erich S. Franz,1,2 Janusz Konrad,2 James A. Hamilton,4 Ning Hua,4
Yorghos Tripodis,14,17 Andrew T. Anderson,18 Gareth R. Howell,10 Daniela Kaufer,12,19
Garth F. Hall,8 Kun P. Lu,13 Richard M. Ransohoff,7,z Robin O. Cleveland,20 Neil
W. Kowall,4,14,16 Thor D. Stein,4,14,16 Bruce T. Lamb,7,$ Bertrand R. Huber,4,14,16,21
William C. Moss,18 Alon Friedman,11,22 Patric K. Stanton,5 Ann C. McKee,4,14,16
Lee E. Goldstein1,2,3,4,6,14
*These authors contributed equally to this work.
The mechanisms underpinning concussion, traumatic brain injury, and chronic traumatic encephalopathy, and the relationships
between these disorders, are poorly understood. We examined post-mortem brains from teenage athletes in the acute-subacute
period after mild closed-head impact injury and found astrocytosis, myelinated axonopathy, microvascular injury, perivascular
neuroinﬂammation, and phosphorylated tau protein pathology. To investigate causal mechanisms, we developed a mouse model of
lateral closed-head impact injury that uses momentum transfer to induce traumatic head acceleration. Unanaesthetized mice
subjected to unilateral impact exhibited abrupt onset, transient course, and rapid resolution of a concussion-like syndrome
characterized by altered arousal, contralateral hemiparesis, truncal ataxia, locomotor and balance impairments, and neurobehavioural deﬁcits. Experimental impact injury was associated with axonopathy, blood–brain barrier disruption, astrocytosis, microgliosis (with activation of triggering receptor expressed on myeloid cells, TREM2), monocyte inﬁltration, and phosphorylated
tauopathy in cerebral cortex ipsilateral and subjacent to impact. Phosphorylated tauopathy was detected in ipsilateral axons by
24 h, bilateral axons and soma by 2 weeks, and distant cortex bilaterally at 5.5 months post-injury. Impact pathologies co-localized
with serum albumin extravasation in the brain that was diagnostically detectable in living mice by dynamic contrast-enhanced
MRI. These pathologies were also accompanied by early, persistent, and bilateral impairment in axonal conduction velocity in the
hippocampus and defective long-term potentiation of synaptic neurotransmission in the medial prefrontal cortex, brain regions
distant from acute brain injury. Surprisingly, acute neurobehavioural deﬁcits at the time of injury did not correlate with blood–
brain barrier disruption, microgliosis, neuroinﬂammation, phosphorylated tauopathy, or electrophysiological dysfunction.
Furthermore, concussion-like deﬁcits were observed after impact injury, but not after blast exposure under experimental conditions
matched for head kinematics. Computational modelling showed that impact injury generated focal point loading on the head and
seven-fold greater peak shear stress in the brain compared to blast exposure. Moreover, intracerebral shear stress peaked before
onset of gross head motion. By comparison, blast induced distributed force loading on the head and diffuse, lower magnitude shear
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stress in the brain. We conclude that force loading mechanics at the time of injury shape acute neurobehavioural responses,
structural brain damage, and neuropathological sequelae triggered by neurotrauma. These results indicate that closed-head
impact injuries, independent of concussive signs, can induce traumatic brain injury as well as early pathologies and functional
sequelae associated with chronic traumatic encephalopathy. These results also shed light on the origins of concussion and relationship to traumatic brain injury and its aftermath.
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Introduction
Closed-head impact injuries are a common cause of concussion (Ropper and Gorson, 2007; Harmon et al., 2013;
McCrory et al., 2013; Sharp and Jenkins, 2015) and traumatic brain injury (TBI) (Langlois et al., 2006; Menon
et al., 2010; Jordan, 2013; Sharp et al., 2016). These injuries are also associated with post-traumatic sequelae
(Guskiewicz et al., 2007a; Ropper and Gorson, 2007;
Blennow et al., 2012; Smith et al., 2013b), including latelife cognitive decline, neurodegenerative disease, and dementia (Guskiewicz et al., 2005; Gavett et al., 2010;
Lehman et al., 2012; Stamm et al., 2015; Stein et al.,
2015b; Montenigro et al., 2017). Emerging evidence implicates repetitive neurotrauma, including sports-related

closed-head impact injuries, as a major risk factor for
later development of chronic traumatic encephalopathy
(CTE), a progressive tau protein neurodegenerative disease
(McKee et al., 2013, 2016; Mez et al., 2017).
An association between sports-related head injuries and
chronic neuropsychiatric disturbances was ﬁrst described
by Martland as the ‘punch-drunk syndrome’ of pugilists
(Martland, 1928). Parker and later Millspauch variously
dubbed the same condition ‘traumatic encephalopathy’
(Parker, 1934) and ‘dementia pugilistica’ (Millspaugh,
1937). Critchley proposed the name ‘chronic traumatic encephalopathy’ (Critchley, 1949, 1957) to capture the progressive long-term nature of the disorder. CTE is now
recognized as a distinct tau protein neurodegenerative disease that is neuropathologically deﬁned by perivascular
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accumulation of abnormally phosphorylated tau protein in
the depths of cortical sulci (McKee et al., 2016). Based on
the presence of this distinctive lesion, CTE has been conﬁrmed in post-mortem brains from individuals across a
wide age range, including teenagers and young adults
(McKee et al., 2013; Bieniek et al., 2015; Mez et al.,
2017). Modern case series have documented CTE neuropathology in contact sport athletes with repetitive concussive and subconcussive head injuries (Omalu et al., 2005;
McKee et al., 2009, 2013; Mez et al., 2017) as well as
military veterans with combat-related blast exposure
(Omalu et al., 2011; Goldstein et al., 2012; Shively et al.,
2016). In addition, deep sulcal tau pathology has been reported in long-term TBI survivors of single-episode neurotrauma (Johnson et al., 2012). While the preponderance of
reported CTE cases include a history of repeated mild TBI,
a subset (20% of cases) is notable for absence of prior
concussion (McKee et al., 2014; Bieniek et al., 2015; Stein
et al., 2015a). This observation suggests that repeated head
injuries, even in the absence of frank concussion, may
induce brain pathologies associated with CTE.
Mild forms of TBI (Kay et al., 1993; Carroll et al., 2004;
Ruff et al., 2009; Menon et al., 2010; Katz et al., 2014;
Kristman et al., 2014) account for the majority of head
injuries worldwide (Roozenbeek et al., 2013; Bazarian
et al., 2014; Gardner and Yaffe, 2015). While the pathogenesis of CTE is unknown, emerging evidence points to a
putative causal association with neurotrauma (Omalu
et al., 2005, 2011; McKee et al., 2009, 2013; Goldstein
et al., 2014; Montenigro et al., 2017). Recent research
has shown that contact sport athletes with repetitive head
injuries and military veterans with blast exposure demonstrate similar patterns of post-mortem CTE neuropathology
(Omalu et al., 2005, 2011; McKee et al., 2009, 2010,
2013; Goldstein et al., 2012; Shively et al., 2016). These
observations support the hypothesis that neurotrauma
induced by different injuries triggers common pathogenic
mechanisms that induce convergent CTE neuropathology.
This hypothesis is further supported by research showing
that laboratory mice exposed to experimental blast develop
progressive brain pathologies and functional sequelae that
resemble CTE in humans (Goldstein et al., 2012; Huber
et al., 2013; Kondo et al., 2015). This experimental work
implicates traumatic head motion as a plausible mechanism
underpinning the observed similarities in human CTE brain
pathology despite differences in the mechanisms of injury.
Based on this evidence, we hypothesized that biomechanical
and pathophysiological determinants underpinning blast
neurotrauma would also drive early CTE neuropathology
after closed-head impact injury (Goldstein et al., 2012;
Ghajari et al., 2017). Furthermore, emerging clinical evidence (Guskiewicz et al., 2007b; Bazarian et al., 2014;
Davenport et al., 2014; Talavage et al., 2014) and clinicopathological correlation analysis (McKee et al., 2013,
2014, 2015; Stein et al., 2015a; Mez et al., 2017) suggest
that TBI and CTE pathobiology may be independent of the
mechanisms that trigger concussion. These observations
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suggest that repeat head injuries, even in the absence of
concussion, may induce TBI and CTE brain pathologies.
Despite growing awareness of links between head injury
and CTE, the substrates and mechanisms underpinning this
association, and relationships to concussion and TBI,
remain largely unknown and matters of signiﬁcant controversy. Most notably, there is insufﬁcient knowledge regarding changes in brain structure and function during the
acute-subacute period after head injury that may represent
the earliest antecedent pathologies of CTE.
Here we developed a novel mouse model of lateral
closed-head concussive impact injury that produces head
kinematics matched to a companion blast neurotrauma
mouse model (Goldstein et al., 2012; Kondo et al.,
2015). We deployed both animal models to test the
hypothesis that neurotrauma induced by different injury
mechanisms triggers common pathogenic mechanisms
and convergent CTE neuropathology. We used nonanaesthetized mice to facilitate comparative investigation
of acute neurobehavioural responses to different types of
neurotrauma. We conducted biomechanical modelling,
computational simulations, and human clinicopathological
correlation analysis to investigate mechanisms leading to
observed differences in acute neurobehavioural responses
and similarities in chronic brain pathologies induced by
neurotrauma.

Materials and methods
Human subjects
The brain and spinal cord from a total of eight teenage and
young adult athletes (Supplementary Table 1), four males with
recent sports-related closed-head impact injuries sustained
1 day to 4 months prior to death (n = 4; ages 17 to 18
years; mean, 17.5 years) and four males without history of
symptomatic impact head injury or neurological disease
(n = 4; ages 17 to 22 years; mean, 19.2 years). Impact exposure, trauma history, and neurological status at the time of
death were determined through review of medical records
and interviews with next of kin. This study was approved by
the Institutional Review Board at Boston University School of
Medicine and conforms to principles of human subject protection in the Declaration of Helsinki.

Animal subjects
Adult male C57BL/6 mice (Charles River Laboratories) and
male CCR2RFP/CX3CR1GFP mice (The Jackson Laboratory),
10–12 weeks of age, were group-housed at the Laboratory
Animal Science Center, Boston University School of
Medicine. B6.129(Cg)-Ccr2tm2.1Ifc/J mice and B6.129PCx3cr1tm1Litt/J were transferred, bred, and utilized for experiments in accordance with the Material Transfer Agreement
between The Jackson Laboratory, Bar Harbor, ME, USA
and Boston University School of Medicine, Boston, MA,
USA. Cohort size was 8–10 per group or as noted. Mice
were provided with standard mouse chow and water ad
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libitum. Ambient temperature was controlled at 20–22 C with
12-h light-dark cycles. Animal experiments were conducted in
accordance with guidelines from the Association for
Assessment and Accreditation of Laboratory Animal Care,
National Research Council Guide for the Care and Use of
Laboratory Animals, and the Laboratory Animal Welfare
Act. Animal experiments were approved by Institutional
Animal Care and Use Committees at Boston University
School of Medicine and New York Medical College. See
Supplementary material for additional details.

Human and murine neuropathology
Post-mortem human brain and spinal cord were received as
fresh tissue and as ﬁxed tissue in formalin after processing
by medical examiners. Neuropathological analysis followed established protocols at the Boston University Alzheimer’s
Disease Center and Chronic Traumatic Encephalopathy
Center and included comprehensive examination for all neurodegenerative conditions (McKee et al., 2013, 2016). Sections
of ﬁxed, parafﬁn-embedded human brain were stained with
Luxol fast blue, haematoxylin and eosin, or processed for
immunohistochemistry or immunohistoﬂuorescence. Mice
were euthanized by CO2 asphyxiation followed by open thoracotomy and transcardial perfusion with phosphate-buffered
saline. Mouse brains were preﬁxed in 10% neutral buffered
formalin, block-sectioned into coronal slabs, post-ﬁxed in 4%
paraformaldehyde, parafﬁn-embedded, and serially sectioned
at 10 mm. Primary detection antibodies for human and
murine brains neuropathology (Goldstein et al., 2012;
McKee et al., 2013; Kondo et al., 2015): glial ﬁbrillary
acidic protein (GFAP) mouse monoclonal antibody GA5
(Millipore), rabbit polyclonal antibody Z0334 (Dako); phosphorylated tau protein (pS202, pT205) mouse monoclonal
antibody AT8 (Pierce Endogen); phosphorylated tau protein
(pS202) mouse monoclonal antibody CP13 (Peter Davies,
Albert Einstein College of Medicine); cis-phosphorylated tau
protein (cis-pT231) mouse monoclonal antibody (Kun Ping
Lu, Harvard Medical School); amyloid precursor protein
(human APP, aa66-81) mouse monoclonal antibody 22C11
(Millipore); phosphorylated neuroﬁlament mouse monoclonal
antibody SMI-34 (Abcam); HLA-DR II (MHC) mouse monoclonal antibody LN3 (Invitrogen); ionized calcium-binding
adaptor molecule 1 (human Iba1, aa135-147) rabbit polyclonal antibody Iba1 (Wako); serum albumin (human SALB)
chicken polyclonal antibody ab106582 (Abcam); phosphorylated Smad2/3 (human Smad2, pS465, pS467) rabbit polyclonal antibody 3101 (Cell Signaling); transforming growth
factor-b complex (TGF-b, human C-terminal peptide) rabbit
polyclonal antibody ab66043 (Abcam). Ultrastructural studies
were conducted on ﬁxed mouse brain specimens embedded in
TM
Epon , sectioned at 60 nm, stained with uranyl acetate or lead
citrate, and examined with a Tecnai-G2 Spirit BioTWIN electron microscope with an AMT 2K CCD camera. See
Supplementary material for additional details.

Experimental closed-head concussive
impact injury
A compressed gas-driven closed-head impact injury system
(Supplementary Fig. 1A) was custom designed and fabricated
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at the Boston University Neurotrauma Laboratory, Boston
University School of Medicine, for use in awake, unanaesthetized
(anaesthesia-naı̈ve) young adult male C57BL/6 mice. The instrument uses a momentum transfer mechanism to deliver a scalable
closed-head impact that results in traumatic head acceleration
without gross skull deformation. As implemented in this study,
left-lateral impact produced right-lateral ﬂexion of the cervical
spine and rightward translation of the head in the horizontal
plane of motion (Fig. 2A and B). Mouse positioning and instrument parameters were set such that head kinematics produced by
experimental impact were comparable to our blast neurotrauma
mouse model (Supplementary Table 2) (Goldstein et al., 2012;
Kondo et al., 2015). Instrument data were acquired and processed in MATLAB (MathWorks, Natick, MA). Animal experiments were conducted without anaesthesia to: maximize clinical
relevance and animal model ﬁdelity with respect to human head
injuries and facilitate accurate assessment of acute neurobehavioural responses post-injury (Huang et al., 2016); maintain
physiological responsivity of central receptors, channels, and
neurotransmitter systems; and prevent anaesthetic modulation
of neuroinﬂammation and tau protein phosphorylation (Planel
et al., 2007; Luh et al., 2011; Wojnarowicz et al., 2017).
Unanaesthetized mice were pretreated with a non-sedating dose
of the analgesic buprenorphine (0.2 mg/kg, i.p.), placed in a modiﬁed DecapiCone (Braintree Scientiﬁc, Inc.), and secured in the
instrument in the prone position. The head and cervical spine
were not restrained during experimental exposure. The singlerepeat design incorporated two impacts separated by 15 min to
mimic a minimal repeat head injury as commonly occurs during
a single session of contact sport play or practice (Crisco et al.,
2010). Experimental head injury was compatible with 100%
survival without evidence of skull fracture, spinal trauma, persistent gross neurological impairment, or post-traumatic apnoea.
See Supplementary material for additional details.

High-speed videography kinematic
analysis
High-speed videography was conducted with a FASTCAM SA5
camera (Photron USA, Inc., Tech Imaging) operated at 10 ms
frame capture rate (100 000 fps; 100 kHz). Videographic records
were reassembled and processed in MATLAB (MathWorks). A
2 kHz second-order, zero-phase Butterworth ﬁlter was applied to
position-time data. First, second, and third derivatives (velocity,
acceleration, jerk) were calculated from the ﬁltered position
versus time vectors using discrete differentiation.

Acute neurobehavioural response
test battery
The test battery is a quantitative multidimensional evaluation
protocol for objective assessment of transient neurobehavioural
responses to experimental neurotrauma in awake, unanaesthetized (anaesthesia-naı̈ve) mice (Supplementary Fig. 1B). A composite score (0–15) was derived by summing component scores
on each of three subtests: open-ﬁeld, inverted wire mesh, beam
walk. Each subtest was conducted over 30 s and scored on a
six-point scale (0–5) based on standardized metrics that capture
graded neurobehavioural deﬁcits speciﬁc for each test
(Supplementary Fig. 1B). A composite score of 15 indicated
unimpaired performance in all three subtests. Lower scores
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indicate increasing impairment (mild: 14–10; moderate: 9–5;
severe: 4–0). Testing was conducted before exposure (preinjury baseline), 2 min after exposure (post-injury), and after
3 h rest period (recovery). See Supplementary material for additional details.

Tau protein immunoblot analysis
Quantitative phosphorylated and total tau protein immunoblot
analyses were conducted on homogenates of left and right
hemisected brains from perfused mice sacriﬁced 2 weeks
after impact injury or sham (no injury) control exposure.
Snap-frozen hemisected brains were thawed, resuspended in
0.7 ml of protease-phosphatase inhibitor buffer, and homogenized. Protein concentrations were normalized and equal
sample volumes analysed by polyacrylamide gel electrophoresis
(Goldstein et al., 2012). Immunoblot detection was conducted
with monoclonal antibody CP-13 (courtesy of Peter Davies,
Albert Einstein College of Medicine) directed against phosphorylated tau protein (pS202) and rabbit polyclonal antibody
Tau 5 (Cell Signaling) directed against total tau protein
(bovine tau, aa210-241). Triplicate measurements were analysed with ImageJ software.

Blood–brain barrier functional
analysis
Mice were injected with Evans blue dye (4 ml/kg, i.p.) 1 h
before impact injury or sham (no-injury) control exposure.
Following sacriﬁce, mice were transcardially perfused with
saline. Gross pathology was documented by photomacroscopy
with a Nikon D5200 digital camera under cross-polarized
white light illumination. Brains were sectioned (2 mm) coronally and imaged with an IVIS Spectrum In Vivo Imaging
System (PerkinElmer). Fluorescence images were acquired at
0.5 s exposure with a 535 nm excitation ﬁlter and the following emission ﬁlters: 580, 600, 620, 640, 660, 680, 700, 720,
740, 760, 780, 800, 820, 840 nm. Non-speciﬁc autoﬂuorescence was removed by spectral unmixing (Living Image software, PerkinElmer). Calibrated images were masked in Adobe
Photoshop and analysed with a custom MATLAB script
(MathWorks, Natick, MA) was used to process pixel data.
Evans blue-speciﬁc ﬂuorescence signal intensity was normalized to pixel area for each masked region. Percentage of
pixels demonstrating Evans blue-speciﬁc ﬂuorescence was calculated by thresholding to the mean 95th percentile of all
counts in control sections. Total percentage of Evans blue extravasation pixels for each mouse brain was calculated by
summation across all slices. Grouping by Evans blue extravasation was performed using a Gaussian mixture model.

Dynamic contrast-enhanced MRI
In vivo T1-weighted and dynamic contrast-enhanced MRI
were performed using a 11.7 T MRI (Bruker) at the Boston
University High-Field NMR Imaging Core Facility. Mice
were anaesthetized with 0.5–2.5% isoﬂurane during imaging
with respiration rate monitoring. For the dynamic sequence,
0.1 ml gadofosveset trisodium (0.25 mmol/ml; Lantheus
Medical Imaging) was administered by tail vein catheter.
Five baseline scans were obtained before injection. After
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injection, 145 scans were acquired over 31 min. Post-acquisition image analysis was performed using customized MATLAB
scripts (MathWorks). See Supplementary material for additional details.

Metallomic imaging mass spectrometry brain mapping
Ultra-trace elemental and isotopic analytical brain mapping for
gadolinium (Gd) was performed by laser ablation-assisted
metallomic imaging mass spectrometry (Gd-MIMS) at the
Boston University Center for Biometallomics. A quadrupole
inductively-coupled plasma mass spectrometer (iCAP-Q,
Thermo Scientiﬁc) was custom hyphenated to a Nd-YAG
laser with frequency quadrupling to attain 213 nm output.
Laser pulse duration was 5 ns with a pulse repetition rate of
20 Hz. Spot size was 20 mm and scan speed was 40 mm/s.
Laser-generated aerosol was transported from a customdesigned laminar ﬂow laser ablation cell to the mass spectrometer by carrier gas mixture at constant ﬂow rates. Generated
ions were transported by mass ﬂow into the mass spectrometer
and separated according to mass-to-charge ratio. Analytical
calibration was performed with a reference standard (SRM
612, NIST). Datasets were exported to a customized
MATLAB program (Mathworks) for analytical processing,
quantitation, and 2D analytical mapping.

Flow cytometry immunophenotyping
Flow cytometry was performed on single-cell suspensions prepared from homogenized brains (Jay et al., 2015). Brieﬂy, cells
were separated on a 30–70% PercollÕ gradient (GE
Healthcare). Single-cell suspensions were stained with a
master mix composed of anti-CD45-APC (1:100; BioLegend),
anti-CD11b-Eﬂuo450 (1:200; eBioscience), anti-Ly-6G-FITC
(1:1000; BioLegend), anti-Ly-6C-PE/Cy7 (1:200; BioLegend),
TREM2-PE (1:100; R&D Systems). Cell populations were
deﬁned
as
inﬂammatory
cells,
CD45 + ;
microglia,
low
+
CD45 CD11b ; and monocytes, CD45highCD11b + Ly-6G–.
Ly-6 C was used to phenotype distinct monocyte subpopulations (Ly-6Chigh, Ly-6Cmiddle, Ly-6Clow). Events were gated on
single cells and CD11b-positive events. Samples with 45000
CD11b-positive events were used for analysis. Fluorescence
Minus One (FMO) was used to assess cells expressing triggering receptor expressed on myeloid cells 2 protein (TREM2 + ).
The percentage of cells from each population was determined
by ﬂow cytometry at the Boston University School of Medicine
Flow Cytometry Core on a LSR-II (BD Biosciences). Analyses
were performed using FlowJo software (FlowJo, LLC, Ashland,
OR). The absolute number of each cell population was calculated as the percentage multiplied by isolated cells per brain.
Signiﬁcant differences between groups were determined by oneway ANOVA with post hoc Student’s t-tests using the
Bonferroni correction. See Supplementary material for additional details.

Hippocampus and medial prefrontal
cortex electrophysiology
Mice were decapitated under deep isoﬂurane anaesthesia and
brains quickly harvested by manual dissection. The forebrain
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was mounted on a cutting stage and immediately submerged in
ice-cold cutting solution (200 mM sucrose, 10 mM NaCl,
2.5 mM KCl, 1.25 mM NaH2PO4, 25 mM NaHCO3, 0.5 mM
CaCl2, 4 mM MgCl2, saturated with 95% O2 and 5% CO2).
Slices containing the hippocampus or medial prefrontal cortex
(Supplementary Figs. 5A–C) were cut by vibratome at 350 mm
thickness. Slices were transferred to an incubation chamber,
warmed to 32 C for 30 min, and equilibrated in a slice recording chamber at 32 C with continuous perfusion (2 ml/min) of
artiﬁcial CSF (10 mM glucose, 126 mM NaCl, 2.5 mM KCl,
1.25 mM NaH2PO4, 1.3 mM MgCl2, 2.5 mM CaCl2, 26 mM
NaHCO3 saturated with 95% O2 and 5% CO2). Axonal conduction velocity was assessed with two recording electrodes
placed in CA1 stratum alveus spaced 200 mm
(Supplementary Fig. 5A). Long-term potentiation (LTP) of synaptic neurotransmission in the medial prefrontal cortex was
assessed with a stimulating electrode placed in mixed inputs
in layer VI and extracellular recording electrode placed as
indicated in Supplementary Fig. 5C. See Supplementary material for additional details.

Mouse headform pressure
measurements
Pressure ﬁlm measurements were conducted with a mouse
headform consisting of a 15 ml polypropylene vial ﬁlled with
10% gelatin. Fuji PrescaleÕ pressure sensitive ﬁlm (Sensor
Products, Inc.) was ﬁxed ﬂush to the outer surface of the
vial and exposed to a single blast or impact under conditions
identical to the in vivo experiments. Control ﬁlms were ﬁxed
to identical headforms and placed in the experimental instruments without impact or blast exposure. Exposed ﬁlms were
digitally scanned, imported into MATLAB (MathWorks), and
converted to monochrome luminescence images (NTSC standard, RGB colour: Y = 0.2989*R + 0.5870*G + 0.1140*B,
equivalent to rgb2gray MatLab). A 1000  500 pixel boundary was applied to all images. Histogram analysis was used to
identify the lower threshold of pixel values attributable to
noise and subtracted from all images. The sum of noise-corrected pixels in the bounded region was measured and
recorded.

Computational simulations
Computational simulations were conducted using ALE3D
(Noble et al., 2017) in explicit dynamics mode with the solid
regions held Lagrangian and the gas regions allowed to advect
and relax to prevent mesh entanglement. All elements for the
impact simulations were 3D linear reduced integration elements, whereas the blast simulations used 2D axisymmetric
reduced integration elements. In all simulations, materials
were initialized to 295 K, and 1 bar ambient pressure, except
gas pressure in the blast tube driver chamber. All materials
were initially at rest, except for the impact rod. Gases were
described by gamma-law gas equations of state ( = 1.4, air;
1.67, He). Predicted blast pressure histories were validated
against analytic solutions for shock tube dynamics
(Liepmann and Roshko, 1957). The skull was modelled as
an isotropic linear elastic hollow sphere with 1.08 cm outer
diameter, 0.02 cm thickness, four radial zones and 2.5
zoning. CSF was modelled as a water layer 0.02 cm thick
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with four radial zones. The brain was modelled as a 0.5-cm
radius viscoelastic sphere, with 30 radial zones. Material properties for the skull and brain were incorporated as previously
described (Moss et al., 2009). The gas zones surrounding the
skull were ratio-zoned, increasing from 0.03 cm thickness at
the skull, to a ﬁxed value of 0.2 cm thickness 4 cm from the
skull centre. The calculated Reynolds number for non-steady
airﬂow in the blast simulation was 105, indicating a turbulent ﬂow ﬁeld, that was accounted for in the simulation. The
sled and impact rod were modelled as linear elastic solids. See
Supplementary material for additional details.

Statistical analyses
Linear mixed-effects regression analyses were used to evaluate
group differences and test for correlation with composite and
subtest scores on the acute neurobehavioural response test battery. Linear mixed-effects regression analyses were also used to
determine group differences of Evans blue extravasation (dyespeciﬁc ﬂuorescence signal intensity) in post-mortem brains. For
each linear mixed-effects regression analysis, we allowed for
outcome-speciﬁc ﬁxed effects and subject-speciﬁc random effects. Outcomes were correlated using an unstructured covariance matrix for within-subject correlation. Mixed effect
analyses represent more realistic outcome models than using
independent regression models for each outcome while removing multiple comparisons and providing greater power
(Goldstein, 2011; Gelman et al., 2012). Immunoblot densitometry and biochemical data were evaluated by two-tailed
Student’s t-test. Flow cytometry data were evaluated by oneway ANOVA followed by post hoc Student’s t-tests using the
Bonferroni correction. Comparisons of axonal conduction velocity and LTP magnitude were made using three-way ANOVA.
Spearman’s rank-order coefﬁcient was computed between lost
points on the test battery and end-point metrics (Supplementary
Table 3). Levels of signiﬁcance: *P 5 0.05; **P 5 0.01;
***P 5 0.001; NS = no signiﬁcant difference. Statistical signiﬁcance was set at an alpha-level of P 5 0.05. Exact P-values are
reported for statistical signiﬁcance except when P 5 0.0001.

Results
CTE pathologies in brains from
teenage athletes in the acute-subacute period after mild closed-head
impact injury
We conducted neuropathological examinations of rare
post-mortem brains obtained from teenage athletes (four
males, aged 17–18 years; mean, 17.5 years;
Supplementary Table 1, Cases 1–4) who sustained sportsrelated closed-head impact injuries and died in the acutesubacute period 1 day to 4 months post-injury (Fig. 1A,
C–J, L, M and O–R). We compared these brains to postmortem control brains from comparably-aged athletes
(four males; aged 17–22 years; mean, 19.2 years;
Supplementary Table 1, Cases 5–8) without recent head
injury (Fig. 1B, K and N). None of the cases showed
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evidence of skull fracture, subdural haematoma, subarachnoid haemorrhage, or other evidence of moderate-tosevere TBI.
We included four cases in the acute-subacute post-TBI
cohort. Case 1, an 18-year-old male high school athlete
(American football, baseball, basketball, weight-lifting)
who died by suicide from hanging 4.2 months after sustaining a mild closed-head injury while snowboarding. The decedent’s head injury exposure history was notable for
amateur participation in American football (9 years total).
He played fullback and middle linebacker, positions associated with frequent high-magnitude head impacts (Crisco
et al., 2011). He sustained 10 concussions, none other than
the last with loss of consciousness. Four months before
death, he sustained a concussion while snowboarding and
brieﬂy lost consciousness (2 min). He was evaluated at a
local hospital and released without follow-up. After the
injury, he complained of frequent headaches and mental
fogginess. His parents noted increased frustration, emotional lability, verbal hostility, physical aggression, and
school absences. He was clinically evaluated and diagnosed
with post-concussive syndrome. Due to school absences,
school ofﬁcials did not allow him to participate in his
high school graduation ceremony. The next day, 4.2
months after the snowboarding injury, he hanged himself
in his bedroom. His past medical history was notable for
attention deﬁcit hyperactivity disorder that was diagnosed
in the third grade and treated for 1 year with methyphenidate. He had no history of depression, anxiety, or prior
episodes of suicidal ideation or suicide attempts. The
intact brain (1460 g) was obtained as a fresh specimen
with a post-mortem interval of 1 day. Grossly, the brain
did not show evidence of atrophy, asymmetry, swelling,
cavum septum pellucidum, or contusions.
Case 2, an 18-year-old male high school athlete
(American football, rugby, soccer, in-line hockey) who
died suddenly 10 days after the second of two sportsrelated head injuries. The decendent’s head injury exposure
history was notable for four sports-related concussions. He
played American football at the amateur level starting at
age 11 and continued intermittently through high school
(3 years total). In his junior and senior year of high
school, he played rugby (amateur then semi-professional
level). One month before death, he sustained a severe concussion during a rugby match that resulted in post-traumatic somnolence. Two weeks later he sustained a second
rugby-related head injury that resulted in sideline collapse
and a 2-day hospitalization for clinical observation and
recuperation. Seven days after hospital discharge, he
engaged in light weightlifting after which he collapsed suddenly while eating dinner with his family. He was taken to
the hospital where he died from acute cerebral oedema, the
recorded cause of death. Selected brain regions were obtained as ﬁxed sectioned specimens on microscope slides.
The brain weight was 1680 g. The post-mortem interval is
not known.
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Case 3, a 17-year-old male high school American football
and lacrosse player who died by suicide from hanging. The
decedent was diagnosed with two sports-related concussions
during life, the last sustained 2 days before death. He was
evaluated in an emergency room after his last head injury (no
reported loss of consciousness) where he was noted to be
confused, could not recall events and circumstances surrounding the injury, and was unable to recite the days of
the week in reverse order. He had no history of depression,
anxiety, mood disorder, impulsivity, suicidal ideation, or
prior suicide attempts. The intact whole brain (1600 g) was
obtained as a fresh specimen with a post-mortem interval of
3 days. Grossly, the brain was diffusely swollen without evidence of atrophy, asymmetry, or contusions. A small anterior
cavum septum pellucidum was noted.
Case 4, a 17-year-old male high school American football
player who sustained three sports-related concussions (26
days, 6 days, 1 day) before death from second impact syndrome. During the football game in which he sustained a
terminal head injury, he received a hard tackle, landed on
his helmet, and was rendered immobile and unresponsive. A
tonic-clonic seizure ensued. He was intubated and ventilated
on the ﬁeld, then transferred to a hospital emergency ward.
A CT head scan showed global cerebral oedema without
evidence of haemorrhage. Despite surgical decompression,
cerebral swelling progressed to fatal brain herniation. He
died 1 day after the proximate head injury. The recorded
cause of death was second impact syndrome. The brain
(1450 g) was obtained as coronal tissue sections on glass
slides. The post-mortem interval is not known.
We included four cases in the control athlete cohort. Case
5, a 19-year-old male high school American football player
who died of multiple organ failure and cardiac arrest. The
intact brain (1430 g) was obtained as a formalin-ﬁxed tissue
specimen with an unknown post-mortem interval. Grossly,
the brain did not show evidence of atrophy, asymmetry,
herniation, or contusions. Case 6, a 19-year-old male college
hockey player with a history of six concussions who died of a
cardiac arrhythmia. The intact brain (1500 g) was obtained as
a formalin-ﬁxed tissue specimen with an unknown postmortem interval. Grossly, the brain did not show evidence
of atrophy, asymmetry, or contusions. Case 7, a 17-year-old
male high school American football player who died from
oxycodone overdose. The brain was obtained as formalinﬁxed coronal slabs of available tissue with an unknown
post-mortem interval. A 0.3-cm cavum septum pellucidum
was noted. Case 8, a 22-year-old male former high school
American football player who died by suicide (unknown
mechanism). The decedent’s head injury exposure history
was notable for three remote concussions, one with loss of
consciousness of indeterminate duration, all sustained more
than 7 years before death. He was diagnosed with bipolar
disorder and had two suicide attempts prior to the completed
suicide. The intact whole brain (1630 g) was obtained as a
fresh tissue specimen with a 2-day post-mortem interval.
Grossly, the brain did not show evidence of atrophy, asymmetry, or contusions.

Early CTE brain pathology after closed-head impact injury
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Figure 1 Post-mortem pathologies in brains from teenage athletes in the acute-subacute period after mild closed-head impact
injury. (A) Coronal brain section immunostained for the astrocytic marker glial fibrillary acid protein (GFAP) in Case 3, a 17-year-old male high
school American football player who died by suicide 2 days after a closed-head impact injury. Widespread GFAP immunoreactivity (brown
staining) indicative of reactive astrocytosis was diffusely present in white matter fibre tracts throughout the brain. Representative whole-mount
brain section, 50 mm thickness. (B) Coronal brain section immunostained for GFAP in control Case 8, a 22-year-old male former high school
American football player without history of recent head injury who died by suicide. GFAP immunoreactivity is restricted to the periventricular
area and diencephalon. Representative whole-mount brain section, 50 mm thickness. (C and D) Haemosiderin-laden macrophages (arrows)
surrounding a small blood vessel consistent with prior microhaemorrhage in Case 1, an 18-year-old male high school American football player
who died by suicide 4 months after a closed-head impact injury. Representative Luxol fast blue haematoxylin and eosin (C) and haematoxylin
(continued)
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Microscopic examination of post-mortem brains from
young athletes in the acute-subacute period after sportsrelated head injury revealed diffuse astrocytosis with
increased glial ﬁbrillary acidic protein immunoreactivity in
white matter (Fig. 1A) and surrounding small blood vessels
in the cerebral cortex (Fig. 1I and J); perivascular foci of
hemosiderin-laden macrophages indicative of resolved
microhaemorrhage (Fig. 1C and D); dystrophic axons with
swellings immunoreactive for amyloid precursor protein
(Fig. 1F–H); perivascular clusters of activated microglia
(Fig. 1L and M) in all four cases. Multifocal axonal
injury was observed diffusely in frontal, temporal, and subcortical white matter. Axonal spheroids and retraction balls
with digestion chambers were noted in the dorsolateral midbrain and cerebellar white matter (Case 1) (McKee et al.,
2014). We detected focal phosphorylated tau protein in two
of the four cases, and early-stage CTE in one case. These
cases were notable for perivascular pretangles, neuroﬁbrillary tangles, dot neurites, and dystrophic axons immunoreactive for phosphorylated tau protein (Fig. 1E and O–R).
Focal cortical lesions demonstrating perivascular accumulation of serum immunoglobulin G (Fig. 1S–U) were detected
in proximity to neighbouring blood vessels of similar calibre
that did not show microvascular pathology (Fig. 1V). These
results are consistent with extravasation and intraparenchymal accumulation of serum proteins secondary to localized
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traumatic microvascular injury and focal blood–brain barrier disruption. By contrast, none of the post-mortem brains
from the control group demonstrated evidence of microvascular or axonal injury, astrocytosis, microgliosis, or
phosphorylated tauopathy indicative of CTE or other neurodegenerative disease (Fig. 1B, K and N). None of the
cases, including those with early CTE pathology, showed
evidence of neuropathology associated with Alzheimer’s disease or other neurodegenerative diseases.

Mechanistic links between
experimental closed-head impact
injury, early CTE pathologies, and
functional sequelae
A novel mouse model of closed-head impact injury
Clinicopathological correlation suggested that impact injury
may, in some cases, trigger early pathologies associated
with CTE. However, causal mechanisms underpinning
this association cannot be established with certainty based
solely on post-mortem neuropathological examination. We
hypothesized that closed-head impact injury is mechanistically linked to, causally determinative of, and temporally
associated with early CTE brain pathologies.

Figure 1 Continued
(D) staining, 10 mm paraffin sections. Scale bars = 100 mm. (E) Case 1, microhaemorrhage surrounded by neurites immunoreactive for phosphorylated tau protein (asterisks) detected by monoclonal antibody AT8 directed against hyperphosphorylated tau protein (pSer202, pThr205)
with haematoxylin counterstain, 10 mm paraffin section. Scale bar = 100 mm. (F–H) Perivascular anti-amyloid precursor protein (APP)-immunoreactive axonal swellings (arrows) in the corpus callosum from Case 3. Representative APP immunostaining with haematoxylin counterstain,
10 mm paraffin sections. Asterisk in G marks a small blood vessel. Scale bars = 100 mm. (I and J) Perivascular astrocytosis in white matter from
Case 3. Representative GFAP immunostaining with haematoxylin counterstain, 10 mm paraffin section (I) and 50 mm free-floating section (J).
Asterisk in I marks a small blood vessel. Scale bars = 100 mm. (K) Minimal GFAP-immunoreactive astrocytosis in the white matter from control
Case 8. Representative GFAP immunostaining, 50 mm free-floating section. Scale bar = 100 mm. (L) Perivascular clusters of activated microglia
around a small blood vessel in the subcortical white matter from Case 4, a 17-year-old male high school American football player who sustained
three closed-head impact injuries 26 days, 6 days, and 1 day before death. Representative LN3 immunostaining directed against human leukocyte
antigen DR-II (HLA-DR II), 50 mm free-floating section. Asterisk indicates small blood vessel. Scale bar = 100 mm. (M) Microgliosis in brainstem
white matter in Case 1. Representative LN3 immunostaining, 50 mm free-floating section. Scale bar = 100 mm. (N) Few activated microglia in
brainstem white matter in control Case 8. Representative LN3 immunostaining, 50 mm free-floating section. Scale bar = 100 mm.
(O) Phosphorylated tau protein-containing neurofibrillary tangles, pretangles, and neurites in the sulcal depths of the cerebral cortex consistent
with neuropathological diagnosis of early-stage CTE in Case 4. Representative CP13 immunostaining directed against hyperphosphorylated tau
protein (pSer202), 50 mm free-floating section. Scale bar = 100 mm. (P and Q) Perivascular dot-like neurites immunoreactive for CP13immunoreactive phosphorylated tau protein in frontal cortex sulcal depths consistent with early-stage CTE in Case 4. Representative CP13
immunostaining, 50 mm free-floating section. Scale bar = 100 mm. (R) Dystrophic axons immunoreactive for CP13-immunoreactive phosphorylated tau protein in frontal cortex white matter in Case 4. Representative CP13 immunostaining, 50 mm free-floating section. Scale bar = 100 mm.
(S) Persistent vascular leakage in Case 1 demonstrated by anti-IgG immohistofluorescence in the brain parenchyma surrounding two blood
vessels (dashed lines, 1 and 2) in the dorsolateral frontal cortex. These findings are consistent with focal blood–brain barrier disruption. Another
blood vessel of similar calibre in the same field (denoted by solid line, number 3) does not exhibit evidence of blood–brain barrier disruption,
consistent with the high degree of focality. Other smaller blood vessels (white arrows) are also devoid of perivascular IgG immunoreactivity,
thereby confirming specificity of the microvascular pathology. Scale bar = 200 mm. (T) High magnification photomicrograph of the same field in
Case 1 showing perivascular IgG immunoreactivity in the brain parenchyma surrounding blood vessel 1 (dashed line, 1). The intensely immunoreactive material in the centre of the lesion is residual blood in the vessel lumen. Two nearby blood vessels (arrows) do not show evidence of
blood–brain barrier disruption. Scale bar = 100 mm. (U) High magnification photomicrograph of the same field in Case 1 showing perivascular IgG
immunoreactivity in the brain parenchyma surrounding blood vessel 2 (dashed line, 2). Scale bar = 100 mm. (V) High magnification photomicrograph of the same field in Case 1 showing the absence of perivascular IgG immunoreactivity in the brain parenchyma surrounding blood
vessel 3 (solid line, 3). Scale bar = 100 mm.
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To test this hypothesis, we developed an experimental
instrument that uses momentum transfer to produce
traumatic head acceleration without gross skull deformation in awake (anaesthesia-naı̈ve) mice. Experimental parameters were optimized to match head kinematics in our
companion blast neurotrauma mouse model (Goldstein
et al., 2012; Kondo et al., 2015). The developed instrument
(Supplementary Fig. 1A) was designed for use in unanaesthetized young adult male mice to model subject variables, injury conditions, and brain pathology as in the
human cases (Goldstein et al., 2014; Wojnarowicz et al.,
2017). The instrument incorporates a gas-driven momentum transfer mechanism to deliver a lateral closed-head
impact that induces traumatic head acceleration without
gross skull deformation (Fig. 2A and B). The rationale
for this design was to enable evaluation of acute neurobehavioural responses and cellular-molecular effects without
confounding interference of systemic anaesthetics (Statler
et al., 2006; Planel et al., 2007, 2008; Fish et al., 2011;
Luh et al., 2011; Whittington et al., 2013; Gao et al.,
2016). Unanaesthetized mice were restrained across the
thorax in the prone position such that the inner pad of
the sled contacted the left temporal-zygomatic region of
the head. Linear translation of the sled resulted in left-lateral closed-head impact, right lateral ﬂexion at the cervical
spine, and traumatic acceleration of the head in the horizontal plane of motion (Fig. 2A and B). Head motion was
assessed by high-speed videography (100 000 fps, 100 kHz).
Sled velocity of 5.1  0.2 m/s [mean  standard deviation
(SD)] produced the following head kinematics (mean 
SD, n = 18): swing radius, 30.0  2.3 mm; peak Xacceleration, 12.6  103  3.4  103 m/s2; peak angular
acceleration, 398.8  111.0 krad/s2; peak X-jerk, 5.3 
107  2.5  107 m/s3 (Fig. 2C). Impact-induced head
kinematics (n = 18) were statistically indistinguishable
(Bonferroni-corrected two-tailed Student’s t-tests, P 4 0.05)
from head motion produced by experimental blast exposure
(n = 8) at a peak pressure of 72.3  2.8 kPag (Goldstein
et al., 2012; Kondo et al., 2015). These results justiﬁed
setting the impact instrument sled velocity at 5.0 m/s and
holding operating parameters constant (Supplementary
Table 2). Experimental impact head injury at this intensity
was compatible with 100% survival without evidence of
skull fracture or deformation; subdural, epidural, or subarachnoid haemorrhage; cervical trauma or spinal cord
injury; post-traumatic apnoea; or persistent gross neurological impairment.

Closed-head impact injury induces acute
neurobehavioural deficits in unanaesthetized mice
Unanaesthetized mice subjected to unilateral closed-head
impact injury exhibited variable degrees of transient neurobehavioural dysfunction with abrupt onset, transient
course, and spontaneous recovery (Supplementary Video
1). To objectively assess this transient concussion-like syndrome, we developed an acute neurobehavioural response
test
battery
and
standardized
scoring
criteria
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(Supplementary Fig. 1B). The test battery consists of three
subtests: open-ﬁeld, inverted wire mesh, and beam walk.
Each 30-s subtest is scored on a six-point scale (0–5) according to graded criteria that capture neurobehavioural
deﬁcits speciﬁc to each subtest (Supplementary Fig. 1B). A
composite score of 15 reﬂects unimpaired performance in
all three subtests. Lower composite scores indicate increasing impairment (mild, 14–10; moderate, 9–5; severe, 4–0).
The test battery was used to assess neurocognitive function
before exposure (pre-injury baseline), after exposure (postinjury), and following a 3-h rest period (recovery).
Awake, unanaesthetized (anaesthesia-naı̈ve) adult male
mice, 10 weeks of age, were exposed to single-repeat
impact injury or sham (no injury) control condition. This
experimental protocol was designed to model a common
head injury scenario in contact sports (Crisco et al., 2010).
A total of 320 adult male mice were subjected to experimental closed-head impact injury (n = 203) or sham (no-injury)
control condition (n = 117). Impact-exposed mice demonstrated signiﬁcant post-injury decrements in composite and
subtest scores on the acute neurobehavioural response test
battery (Fig. 2D). Sled velocity (between 3.75 m/s and
6.25 m/s) did not signiﬁcantly correlate with test battery
composite scores (Spearman r = 0.16, P = 0.025, n = 203).
However, the signiﬁcant decrement in composite scores detected after second impact (Fig. 2D) showed signiﬁcant positive correlation with composite scores after ﬁrst impact
(Spearman r = 0.52, P 5 0.0001, n = 203). Post-traumatic
deﬁcits were noted only in impact-injured mice, spanned
multiple functional domains, and followed a transient
course with spontaneous recovery (Fig. 2D). Mean composite test battery scores showed a highly signiﬁcant difference
between impact and control groups (linear mixed-effects regression analysis, P 5 0.0001). Comparisons within the
impact group revealed a signiﬁcant decrement in mean composite score from baseline (pre-injury) to ﬁrst post-injury
tests [mean  standard error of the mean (SEM):
14.9  0.0, 11.6  0.2; P 5 0.0001] and further signiﬁcant
decrement after second impact (mean  SEM: 10.1  0.2;
P 5 0.0001). There were no signiﬁcant differences in composite or subtest scores in the control group at any time
point. Impact-injured mice demonstrated spontaneous recovery with complete resolution of deﬁcits and return to baseline (pre-injury) performance by 3 h post-injury
(mean  SEM: 14.8  0.0).
Despite tight control of the experimental injury parameters, the spectrum of acute neurobehavioural responses
showed wide variation with skewing towards the milder
end of the spectrum (Fig. 2E and F). 81.8% (n = 166/
203) of all impact-injured mice exhibited minimal or no
acute neurological impairment (composite test battery
score 510) post-injury (Supplementary Video 1, Mouse
P-238). Nearly two-thirds of these mice (66.5%; n = 135)
showed minimal or no acute neurological impairment after
a second head injury. 15.8% (n = 32/203) of all impactinjured mice demonstrated transient unilateral acute neurological impairment (composite score 9–5) post-injury
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Figure 2 Experimental closed-head impact injury in awake, unanaesthetized (anaesthesia-naı̈ve) mice induces abrupt onset,
transient course, and rapid resolution of neurobehavioural impairments that resemble human concussion. (A and B) Schematic of
momentum transfer instrument before (A) and after (B) experimental closed-head impact injury. The developed instrument was designed for use
with unanaesthetized C57BL/6 mice and is compatible with 100% survival without evidence of skull fracture; subdural, epidural, or subarachnoid
haemorrhage; cervical trauma or spinal cord injury; commotio cordis or retinae; or post-traumatic apnoea. Animal subjects are secured across the
thorax and positioned prone such that the head is in physical contact with a helmet analogue composed of an inner foam pad (P) and an outer hard
shell (Sh) fixed to a mobile sled (S). Sled movement is constrained to linear translation by a low-friction monorail track (not shown). Sled motion
is initiated by an operator-triggered computer program that actuates a solenoid valve, releases a bolus of pressurized gas, and accelerates a
stainless-steel slug within the instrument barrel. Vent holes in the barrel convert slug motion to constant velocity. Sequential momentum transfer
from the slug to a captive stainless-steel rod (R; known mass, mr, empirically-determined velocity, vr) and finally to the sled (S; known mass, ms,
empirically-determined velocity, vs). Sled motion results in closure of the distal gap (G1), opening of the proximal gap (G2), and termination by the
backstop (B). A detailed schematic of the developed instrument is shown in Supplementary Fig. 1A. (C) Head motion analysis (time-history plot)
during experimental closed-head impact injury reconstructed from high-speed videographic records (100 000 fps; 100 kHz). Head position,
acceleration, and jerk are plotted as a function of time after initiation of head motion (t = 0). Maximal head acceleration and jerk are observed
within the first millisecond after impact. Experimental parameters were selected to kinematically match head motion in our blast neurotrauma
mouse model (Supplementary Table 2). Blue dashed line, mean peak X-acceleration (n = 18 mice). Red dashed line, mean peak X-jerk (n = 18
mice). (D) Composite and subtest scores on the acute neurobehavioural response test battery (Supplementary Fig. 1B) assessed in awake
unanaesthetized (anaesthesia-naı̈ve) mice: (i) at pre-injury (baseline test); (ii) at 2 min after experimental closed-head impact injury (IMP) or
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(Supplementary Video 1, Mouse L-070). The observed
motor deﬁcits in this group were exclusively ipsilateral
with respect to impact (i.e. left-lateral impact induced
right-sided neurological deﬁcits). Only rarely (2.5%,
n = 5/203) did we observe mice that demonstrated global
neurological impairment (sustained immobility or frank
seizure; composite test battery score 4 4) after the ﬁrst
impact (Supplementary Video 1, Mouse P-199). Severe
global responses were rare (n = 13, 6.4%) after the
second impact. Head-injured mice recovered to neurological baseline, typically within minutes and always by
the end of the 3-h recovery period (Fig. 2E, F and
Supplementary Video 1).

Closed-head impact injury induces early CTE brain
pathologies in unanaesthetized mice
Previous research in our laboratory and others pointed to
the intensity of traumatic head motion, rather than the type
of insult, as the causally determinative mechanism that triggers CTE brain pathologies (Goldstein et al., 2012; Huber
et al., 2013; Kondo et al., 2015). To test this hypothesis,
we set experimental parameters in our impact injury mouse
model such that head motion was kinematically comparable to our blast model (Supplementary Table 2). We
hypothesized that impact injury would initiate shearing
forces in the brain, thereby causing microvascular injury,
reactive neuroinﬂammation, and accumulation of pathogenic species of phosphorylated tau protein similar to the
cascade triggered by blast exposure (Goldstein et al., 2012;
Huber et al., 2013; Kondo et al., 2015). To investigate this
hypothesis, we examined brains from mice sacriﬁced 24 h,
3 days, and 2 weeks after single-repeat left-lateral impact
injury (24 h post-injury: impact-injured mice, n = 7; uninjured sham control mice, n = 3; 3 days post-injury: impact,
n = 6; sham, n = 2; 2 weeks post-injury: impact, n = 7;
sham, n = 3; 5.5 months post-injury, cis-p-tau only:
impact, n = 3; sham, n = 1). In contrast to the diffuse
brain pathology noted after blast exposure (Goldstein
et al., 2012), the brain lesions observed after lateral
impact injury localized predominantly to ipsilateral cerebral
cortex subjacent to the impact contact zone (Fig. 3).
Affected brain regions included left perirhinal, insular,
entorhinal, and piriform cortices, as well as adjacent
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regions of the left basolateral amygdala. Histopathological
examination of brains 24 h post-injury revealed shrunken
acidophilic neurons with eosinophilic cytoplasm and
pyknotic basophilic nuclei at various stages of degeneration
(Fig. 3A). Dystrophic axons (Fig. 3D) containing hyperphosphorylated neuroﬁlaments were observed in proximity to
activated astrocytes (Fig. 3G) and reactive microglia
(Fig. 3J). By 3 days post-injury, we observed decreased
neuronal density indicative of neuronal demise, brisk astrocytosis and reactive microgliosis in the ipsilateral perirhinal
cortex (Fig. 3B, E, H and K). By 2 weeks post-injury, we
noted regions of markedly decreased neuronal density,
resolving astrocytosis and microgliosis, and clusters of perivascular hemosiderin-laden macrophages (Fig. 3C, F, I and
L). The contralateral perirhinal cortex was histopathologically normal at all three time points. We did not detect
trauma-related brain pathology in uninjured control mice
(Supplementary Fig. 2A–O). Neuropathological analysis of
post-mortem brains from mice subjected to a single exposure closed-head impact (24 h post-injury: impact, n = 6;
sham, n = 3; 3 days post-injury: impact, n = 6; sham,
n = 3; 2 weeks post-injury: impact, n = 5; sham, n = 3)
under identical experimental conditions revealed a similar
pattern and time course of TBI-related brain pathologies
(Supplementary Fig. 3) as that observed in brains of mice
exposed to two impacts.
Analysis of phosphorylated tauopathy revealed a more
complex pattern. Post-mortem brains at 24 h, 3 days, and
2 weeks post-injury did not reveal evidence of neuronal or
astroglial phosphorylated tauopathy when probed with a
monoclonal antibody directed against a mature tau proteoform phosphorylated at serine residue 202 (CP13; pSer202;
Fig. 3M–O). However, we detected robust immunostaining
with the monoclonal antibody cis-p-tau directed against a
highly pathogenic phosphorylated tau proteoform with the
cis-Thr231-Pro motif, an early driver of tau-mediated
neurotoxicity in Alzheimer’s disease and TBI (Nakamura
et al., 2012; Kondo et al., 2015; Lu et al., 2016). Cis-ptau immunostaining (Fig. 3P–W) revealed pronounced
axonal pathology in ipsilateral perirhinal cortex as early
as 24 h post-injury. Importantly, cis-p-tau was not detected
elsewhere in the brain at this early time point nor in brains
from control mice at any time point (Supplementary Fig.

Figure 2 Continued
exposure to the sham (no injury) control condition (CON) (post-injury test); and (iii) after a 3-h rest period (recovery test). Mice subjected to
experimental impact injury showed significant decrements in composite scores and all three sub-test scores (open-field, inverted wire mesh, beam
walk). IMP, n = 203 mice. CON; n = 117. Values represent means  SEM. ***P 5 0.001. Transient neurobehavioural impairments spanned multiple
functional domains (including arousal, responsivity to environmental stimuli, locomotion, exploration, motor performance, habituation) that
recapitulate features of concussion in humans (Supplementary Video 1). (E) Histogram and box-and-whiskers plot for population frequency
distribution of composite scores on the acute neurobehavioural response test battery at baseline (pre-impact) and after first impact in awake
(anaesthesia-naı̈ve) mice exposed to experimental closed-head injury (n = 203). Baseline test: median score, 15; mean  SEM, 14.9  0.0 (whitebordered black inverted triangle). Impact 1 test: median score, 12; mean  SEM, 11.6  0.2 (black inverted triangle). (F) Histogram and box-andwhiskers plot for population (n = 203) frequency distribution of composite scores on the acute neurobehavioural response test battery after
second impact and 3-h recovery. Impact 2 test: median score, 11; mean, 10.1  0.2 (black inverted triangle). Recovery test: median score, 15;
mean, 14.8  0.0 (white-bordered black inverted triangle).
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Figure 3 Experimental closed-head injury induces early and progressive brain pathologies associated with CTE in cerebral
cortex ipsilateral and subjacent to impact. (A–C) Luxol fast blue haematoxylin and eosin (LHE) staining in ipsilateral (left) perirhinal cortex
24 h (A), 3 days (B), 2 weeks (C) post-injury. (A) LHE staining at 24 h post-injury revealed dying neurons (arrows) with pyknotic basophilic nuclei
and intensely eosinophilic cytoplasm interspersed with normal-appearing neurons (arrowheads). Black box, magnified view showing neuronal
necrosis. Scale bar = 100 mm. (B) Decreased neuronal density (below line) indicative of neuronal demise, ipsilateral (left) perirhinal cortex 3 days
post-injury. Normal-appearing neurons (arrowheads, above line). Scale bar = 100 mm. (C) Decreased neuronal density (below line) indicative of
neuronal demise and gliosis near a small blood vessel (between dashed lines). Clusters of haemosiderin-laden macrophage (darts) represent
microhaemorrhage residua. Scale bar = 100 mm. Contralateral (right) perirhinal cortex was histopathologically normal by LHE staining
(Supplementary Fig. 2A–C). (D–F) Immunostaining with monoclonal antibody SMI-34 (phosphorylated neurofilament) in ipsilateral (left) perirhinal
cortex 24 h (D), 3 days (E), 2 weeks (F) post-injury. (D and E) SMI-34 immunostaining revealed neurons with swollen, beaded neuronal processes
(arrowheads) and cytoplasmic immunoreactivity (arrow, E). Scale bars = 100 mm. (F) Haemosiderin-laden macrophages (darts), but not SMI-34
immunoreactivity, were observed in the ipsilateral (left) perirhinal cortex 2 weeks post-injury. Scale bar = 100 mm. Contralateral (right) perirhinal
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2P–W). By 3 days and 2 weeks post-injury, cis-p-tau immunoreactivity was present not only in axons but also as dotlike puncta that were miscompartmentalized in the soma
and dendrites of neurons in the ipsilateral (left) perirhinal
cortex, and to a lesser degree, contralateral (right) perirhinal cortex. Surprisingly, cis-p-tau immunoreactivity was
robustly present in perirhinal and primary motor cortices of
both hemispheres 5.5 months post-injury (Fig. 3S and W).
The presence of bilateral cis-p-tau immunoreactivity at this
remote post-injury time point, and in brain regions distant
from the primary locus of brain injury, suggests either extreme persistence of incipient tauopathy, or alternatively,
progressive tauopathy involving spread beyond the originating injury (see ‘Discussion’ section). Neuropathological
analysis of post-mortem brains from mice subjected to a
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single closed-head impact (Supplementary Fig. 3Y–HH) revealed a similar pattern and time course of tau protein
pathologies as that observed in brains of mice exposed to
two impacts.
Perivascular accumulation of phosphorylated tau protein
in the depths of cortical sulci represents the deﬁning pathological hallmark of CTE (McKee et al., 2016) and points to
traumatic microvascular injury (Kenney et al., 2016) as a
likely contributor to CTE pathogenesis. To test the hypothesis that experimental impact injury induces traumatic
microvascular injury, we conducted electron microscopic
analysis of brains from mice 2 weeks post-injury.
Ultrastructural examination of these brains revealed evidence of persistent, focal microvascular injury notable for
dysmorphic capillaries; abnormal endothelial cells with

Figure 3 Continued
cortex was histopathologically normal by SMI-34 immunostaining (Supplementary Fig. 2D–F). (G–I) Immunostaining for astrocytic glial fibrillary
acidic protein (GFAP) in ipsilateral (left) perirhinal cortex 24 h (D), 3 days (E), 2 weeks (F) post-injury. (G) Sparse GFAP-immunoreactivity
(arrowhead) was present 24 h post-injury. Scale bar = 50 mm. (H) Brisk reactive astrocytosis at 3 days post-injury. Clusters of hypertrophied
GFAP-immunopositive reactive astrocytes (arrowheads) with ramified processes and perivascular astrocytes (arrow) with hydropic end-feet
terminating on small blood vessels (dashed lines) were present 3 days post-injury. Overlapping astrocytic processes (black circle) indicate
disruption of domain restriction. Scale bars = 50 mm. (I) Reactive astrocytes (arrowheads) were present 2 weeks post-injury. Haemosiderin-laden
macrophages (darts), representing microhaemorrhage residua, were scattered throughout the affected region. Scale bar = 50 mm. Contralateral
(right) perirhinal cortex was histopathologically normal by GFAP immunostaining (Supplementary Fig. 2G–I). (J–L) Immunostaining for the
myeloid cell marker Iba1 (arrowheads) in ipsilateral (left) perirhinal cortex revealed minimal microgliosis at 24 h (J), brisk microgliosis at 3 days
(K), resolved microgliosis at 2 weeks (L) post-injury. Scale bars = 50 mm. (K) Peak microgliosis at 3 days post-injury revealed clusters of intensely
Iba1-immunoreactive, ramified myeloid cells (arrowheads) and less abundant amoeboid and rodlike Iba1-immunoreactive microglia (open and halffilled arrowheads, respectively). Iba1-immunoreactive perivascular myeloid cells were associated with the parenchymal (abluminal) surface of a
small blood vessel (between dashed lines). Scale bar = 50 mm. (L) Microgliosis was largely resolved by 2 weeks post-injury. Haemosiderin-laden
macrophage (darts) were observed throughout the affected region. Scale bar = 50 mm. Contralateral (right) perirhinal cortex was histopathologically normal by Iba1 immunostaining (Supplementary Fig. 2J–L). (M–O) Phosphorylated tau protein immunostaining with monoclonal antibody
CP13 (pS202) was negative throughout the brain at 24 h (M), 3 days (N), and 2 weeks (O) post-injury. Haemosiderin-laden macrophage (darts)
were observed throughout the affected region by 2 weeks post-injury (O). Scale bars = 50 mm. The contralateral (right) perirhinal cortex did not
demonstrate CP13 immunostaining (Supplementary Fig. 2M–O). (P–W) Immunohistofluorescence staining for cis-p-tau (cis-motif, pThr231-Pro),
a highly pathogenic early phosphorylated tau proteoform, was present at 24 h (P), 3 days (Q), 2 weeks (R), and 5.5 months (S) post-injury in
ipsilateral (left) perirhinal cortex. Faint cis-p-tau immunoreactivity was observed in axons (arrowheads) in the ipsilateral (left, P) but not
contralateral (right, T) perirhinal cortex 24 h post-injury. By 3 days post-injury, cis-p-tau immunoreactivity in the ipsilateral perirhinal cortex (Q)
was intense, not only in axons (arrowheads), but also as dot-like inclusions in neuronal soma and dendrites (arrow). Cis-p-tau immunoreactivity in
the contralateral perirhinal cortex (U) was present but faint at this time point. By 2 weeks post-injury, cis-p-tau immunoreactivity was observed in
axons (arrowheads) and as dot-like inclusions in neuronal soma and dendrites (arrow) in both hemispheres. Cis-p-tau immunoreactivity was more
pronounced in the ipsilateral (left, R) than contralateral (right, V) perirhinal cortex. Surprisingly, we detected cis-p-tau immunoreactivity 5.5
months post-injury (the longest time point measured) in axons (arrowheads) and as dot-like inclusions in neuronal soma and dendrites (arrow) in
perirhinal cortex of both hemispheres (left, S; right, W). Scale bars = 20 mm. Sham (no-injury) control mice did not show evidence of cis-p-tau
immunoreactivity in either hemisphere at any of the analysed time points (Supplementary Fig. 2P–W). (X–AA) Ultrastructural evidence of
persistent traumatic microvascular injury revealed by electron microscopy 2 weeks post-injury. (X) Low-power electron micrograph of CA1
region of the left hippocampus shows abnormal capillary (c) and nearby neuron (n). A capillary endothelial cell (e) and adjacent pericyte (p) are
encircled by hydropic astrocytic end-feet (ae). Perivascular astrocyte processes exhibit pale oedematous cytoplasm with few mitochondria (m),
subcellular organelles, or cytoskeletal elements. The capillary basal lamina is thickened, highly branched, and tortuous. Electron-dense inclusion
bodies (open arrowheads) and lipofuscin granules with lipid droplets (partially-filled arrowhead) are evident. These ultrastructural pathologies are
inconsistent with processing artefact. Magnification 1500. Scale bar = 2 mm. (Y) Low-power electron micrograph of left medial prefrontal
cortex 2 weeks after injury shows an abnormal capillary (c) and two nearby neurons, one with normal ultrastructure (n1) and the other
undergoing cellular involution (n2). Endothelial cell (e), perivascular pericyte (p), and hydropic astrocytic end-feet (ae) are present. Magnification
 1200. Scale bar = 2 mm. (Z) Electron micrograph of the CA1 region of the left hippocampus shows a hydropic astrocytic end-foot (ae) and
pericyte (p) of an involuting capillary. The basal laminae are thickened and tortuous (arrowheads). Electron-dense inclusion body (i), swollen
mitochondria (m), and autophagosomic vacuoles (v, dashed ellipse) are present. Magnification  3000. Scale bar = 2 mm. (AA) High magnification
electron micrograph of the same CA1 region of the left hippocampus showing ultrastructural details of the hydropic astrocytic end-foot (ae) and
pericyte (p). Thickened, tortuous basal lamina (arrowheads), inclusion body (i), swollen mitochondrion (m), and degenerating mitochondrion
(asterisk) are present. Magnification 10 000. Scale bar = 500 nm. n = 4 mice per group.
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irregularly shaped nuclei and thickened, tortuous basal
laminae; and perivascular astrocytes with grossly enlarged,
highly-vacuolated, hydropic end-feet (Fig. 3X–AA).
Perivascular astrocytes and pericytes in the perirhinal
cortex, hippocampus, and frontal cortex were also notable
for electron-dense inclusion bodies, lipofuscin granules,
myelin ﬁgures, and autophagosomic vesicles. Pericytes,
microglial cells, dystrophic nerve ﬁbres, and dark neurons
were observed in proximity to small blood vessels in brains
from impact-injured mice but not uninjured controls. These
ﬁndings provide direct evidence that experimental closedhead impact injury damages small blood vessels and induces persistent focal traumatic microvascular injury
(Goldstein et al., 2012; Huber et al., 2013; Hay et al.,
2015; Doherty et al., 2016; Kenney et al., 2016).

Closed-head impact injury triggers differential
expression of phosphorylated tau proteoforms
Given the effects of closed-head impact on the microvasculature and induction of cis-p-tauopathy, we were surprised
by the absence of mature tau protein neuropathology in
impact-injured mice (Fig. 3M–O). We hypothesized that
epitopes detected by cis-p-tau (cis-pThr231) and CP13
(pSer202) antibodies represent earlier and later stage tauopathy, respectively. To investigate the possible presence of
CP13-immunoreactive molecular pathology, we performed
quantitative tau protein immunoblot analysis of brains
from impact-injured mice (n = 16) compared to sham (uninjured) control mice (n = 14) (Fig. 4). We detected a signiﬁcant increase in both the intensity and mobility range
of CP13-immunoreactive phosphorylated tau protein in
brains from impact-injured mice compared to controls
(Bonferroni-corrected
two-tailed
Student’s
t-test,
P = 0.006). This effect was accompanied by a signiﬁcant
increase in total tau protein (Tau5) (P = 0.001), indicating
accumulation of both phosphorylated and non-phosphorylated tau protein species. Increased brain levels of tau protein were detected bilaterally. Also notable was the increase
in higher apparent molecular weight tau protein species in
the contralateral compared to ipsilateral hemispheres of
impact-injured mice. This ﬁnding may indicate differences
in tau protein phosphorylation or proteoform composition
at sites of traumatic injury compared to brain regions affected by latent tau propagation or spread.
Relationship of traumatic microvascular injury to
early CTE tau pathology
Neuropathological examination of teenage athlete brains in
the acute-subacute period after closed-head impact injuries
(Fig. 1) and histopathological and ultrastructural analyses
of brains from impact-injured mice (Fig. 3) suggested traumatic microvascular injury and blood–brain barrier disruption as candidate mechanisms linking closed-head impact to
acute brain injury and chronic post-traumatic sequelae
(Martland, 1928; Hay et al., 2015; Doherty et al., 2016;
Kenney et al., 2016), including CTE (Goldstein et al., 2012;
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McKee et al., 2013, 2016). To investigate this hypothesis,
we injected mice with Evans blue, an albumin-binding sulphonated diazo dye (960 Da) that is normally excluded
from the brain by an intact blood–brain barrier (Rawson,
1943; Povlishock, 1998). Examination of post-mortem
brains from Evans blue-injected mice sacriﬁced 24 h after
left-lateral impact injury (n = 12) or the uninjured sham
control condition (n = 7) revealed a spectrum of macroscopic pathologies (Fig. 5A). Brains from 50% of
impact-injured mice were grossly normal and showed no
evidence of Evans blue extravasation, contusion, necrosis,
haematoma, haemorrhage, or other gross brain pathologies
(Grade 0; Fig. 5A). Brains from 40% of impact-injured
mice demonstrated faint Evans blue extravasation without
evidence of frank haemorrhage, haematoma, or contusion
(Grade I; Fig. 5A). These focal lesions localized exclusively
to the lateral surface of the ipsilateral perirhinal cortex
subjacent to the impact contact zone. Together, these two
classes of normal or minor brain pathology (Grades 0 and
I, respectively) constituted 90% of the experimentally
head-injured mice. By contrast, brains from 10% of
impact-injured mice exhibited focal contusions with petechial haemorrhages surrounded by a penumbra of extravasated Evans blue dye (Grade II; Fig. 5A). These complex
lesions localized exclusively to surface cortex ipsilateral to
impact. Evidence of gross neuropathology (Grades I, II) in
50% of impact-injured mice contrasts with the absence of
gross pathology in all mice exposed to experimental blast
under conditions of comparable head kinematics (Goldstein
et al., 2012).
We conﬁrmed blood–brain barrier disruption by quantitative Evans blue ﬂuorescence brain imaging (Fig. 5B–D).
Evans blue-speciﬁc ﬂuorescence signal intensity was determined after spectral unmixing to remove background
autoﬂuorescence. Cluster analysis using a Gaussian mixture
model (Fig. 5D) identiﬁed three distinct injury classes based
on ﬂuorescence signal intensity: Grade 0, intact blood–
brain barrier (411.4  83.3 counts/pixel, 2.9  1.7%
suprathreshold pixels); Grade I, minor blood–brain barrier
disruption (707.5  191.2 counts/pixel, 18.8  6.2%
suprathreshold pixels); Grade II, severe blood–brain barrier
disruption (1203.6  210.5 counts/pixel, 58.4  8.2%
suprathreshold pixels). In the control group (n = 7), six
mice (86%) were classiﬁed as Grade 0, one mouse (14%)
as Grade I, and none (0%) as Grade II. In the impact group
(n = 12), ﬁve mice were classiﬁed as Grade 0 (42%), ﬁve
mice (42%) as Grade I, and two mice (17%) as Grade II.
The three injury classes mirrored the groups identiﬁed by
gross pathology (Fig. 5A). Inclusion of all groups revealed a
statistically signiﬁcant effect of impact on ipsilateral blood–
brain barrier disruption when compared to control (linear
mixed-effects regression analysis, P = 0.0004; Fig. 5C).
Consistent with the post-injury neuropathology (Fig. 3),
blood–brain barrier disruption was not detected in the
contralateral hemisphere of brains from impact-injured
mice.

Early CTE brain pathology after closed-head impact injury
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Figure 4 Unilateral closed-head impact injury induces persistent bilateral phosphorylated tau proteinopathy in awake, anaesthesia-naı̈ve mice. (A–H) Phosphorylated tau protein immunoblot analysis of brain homogenates from left and right hemispheres from mice
exposed to experimental left-lateral closed-head impact injury (IMP) or sham (no injury) control exposure (CON) probed for total tau protein
(Tau 5; A, C, E and G), phosphorylated tau protein (CP-13, pSer202; B, D, F and H), and b-actin (A–H) 2 weeks after CON (lanes 1–4, 9–12) or
IMP (lanes 5–8, 13–16) exposure. Immunoblot analysis revealed a broad band of CP-13-immunoreactive phosphorylated tau protein that migrated
with an apparent molecular mass of 53 kD (arrows). (I–L) Densitometric quantitation of total tau protein (I and K) and CP-13 phosphorylated tau
protein (J and L) in brain homogenates from mice 2 weeks after IMP or CON exposure. n = 8 mice per group, mean values  SEM in arbitrary
densitometric units (a.u.) normalized to control values. ***P 5 0.001, **P 5 0.01 (unpaired two-tailed Student’s t-test).

These results suggested mechanistic links between impactinduced traumatic microvascular injury and pathological
and functional sequelae associated with closed-head
impact injury. Since impact injury was associated with ipsilateral blood–brain barrier disruption, we investigated the
possibility that mild TBI may promote non-haemorrhagic
accumulation of extravasated serum albumin in the brain.
Mice subjected to unilateral impact demonstrated robust
evidence of ipsilateral serum albumin extravasation and
co-localizing reactive astrocytosis (Fig. 5H–P; cf. 5E–G).
Focal albumin deposition and co-localizing reactive astrocytosis were detected exclusively in ipsilateral (left) perirhinal cortex in impact-injured mice (Fig. 5H–J) but not
in any brain region in control mice (Fig. 5E–G and
Supplementary Fig. 2). Peak signals for extravasated
serum albumin and astrocytosis co-localized at 3 days
post-injury in impact-injured mice. Extravasated albumin
also co-localized with TGF-b1-associated astrocytosis and
downstream markers of transforming growth factor beta
signalling, in ipsilateral (Fig. 5K–P; Supplementary Fig.
4A and D) but not in contralateral perirhinal cortex of
impact-injured mice (Supplementary Fig. 4B and E) or in

any brain region of uninjured control mice (Supplementary
Fig. 4C and F).

In vivo detection of traumatic microvascular injury by
dynamic brain imaging
We reasoned that the blood–brain barrier disruption we
detected ex vivo (Fig. 5A–P) would be detectable in vivo
using a modiﬁed dynamic contrast-enhanced MRI strategy
(Weissberg et al., 2014) combined with systemically administered gadofosveset trisodium, a gadolinium-based contrast
agent that binds albumin (Lauffer et al., 1998). We performed a proof-of-concept feasibility study to validate this
strategy for in vivo diagnostic evaluation of traumatic
microvascular injury. In vivo dynamic neuroimaging combined with systemic administration of gadofosveset trisodium conﬁrmed acute and persistent blood–brain barrier
disruption in left but not right perirhinal cortex (ipsilateral
and contralateral to impact, respectively) in impact-injured
mice but not control mice (Fig. 5S–T). The ipsilateral
blood–brain barrier permeability defect in impact-injured
mice co-localized with T1-weighted hyperintensities in the
affected cortical ﬁeld (Fig. 5Q–R). Blood–brain barrier
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Figure 5 Unilateral, closed-head impact injury induces focal blood–brain barrier disruption, serum albumin extravasation,
astrocytosis, myeloid inflammatory cell infiltration, and TREM2 + microglial activation in cerebral cortex ipsilateral and subjacent to impact. (A) Gross pathology in representative brains from a control mouse (CON) exposed to sham (no injury) control condition
compared to brains from mice subjected to experimental closed-head impact injury (IMP) with varying degrees of gross brain pathology (Grade 0,
I, II, respectively) 24 h post-injury. Grade 0: absence of gross brain pathology with no evidence of macroscopic tissue damage (contusion, necrosis,
hematoma, haemorrhage, or extravasated Evans blue) was observed in 100% of brains from CON mice and 50% of brains from IMP mice. Grade
I: minimal brain pathology marked only by focal Evans blue extravasation (indicative of disruption of the blood–brain barrier, BBB) was observed in
40% of IMP mice but none (0%) of the CON mice. Grade II: relatively rare brains marked by complex lesions that included Evans blue
extravasation and contusion observed in 10% of IMP mice but none (0%) in CON mice. (B) Evans blue-specific fluorescence imaging of
representative mouse brain sections showing blood–brain barrier disruption 24 h post-injury. Arrows, left-lateral fluorescence signal indicating
area of blood–brain barrier disruption (in Evans blue-specific fluorescence intensity counts) in cerebral cortex ipsilateral and subjacent to
experimental impact injury (IMP) but not sham (no-injury) control condition (CON). Serial brain sections (anterior to caudal, S1–S4, respectively)
and gross pathology injury grade (0, I, II) as indicated. (C) Quantitative analysis of blood–brain barrier disruption by coronal section Evans bluespecific fluorescence brain imaging 24 h after IMP or CON exposure. Blood–brain barrier disruption localized to the perirhinal, insular, entorhinal,
and piriform cortices and basolateral amygdala of the left hemisphere ipsilateral and subjacent to the impact contact zone. Inset: rostral-to-caudal
brain sections, S1–S4. ***P 5 0.001; NS = not statistically different. (D) Gaussian mixed model analysis of Evans blue fluorescence brain imaging
yielded three groups that corresponded to gross pathology classification (Grades 0, I, II). (E–J) Anatomical localization of extravasated serum
albumin (SALB; E, G, H and J) and co-localizing reactive astrocytosis (GFAP; F, G, I and J) in left perirhinal cortex ipsilateral to impact 3 days postinjury (H–J) but not in corresponding cortex from CON mice (E–G). DAPI (blue channel: F, G, I and J), cell nuclei. Hashed lines (H–J) demarcate
cortical region with maximal post-injury serum albumin extravasation (H and J) and co-localization with reactive astrocytosis (I and J).
Arrowheads, GFAP-immunopositive processes of activated astrocytes. Scale bars = 100 mm. (K–P) Left perirhinal cortex at peak of reactive
astrocytosis 3 days post-injury. Composite fluorescence microscopic images showing co-localization of extravasated serum albumin (SALB, red: K,
L, M and O) with reactive astrocytosis (GFAP, green: K, L, M and P); TGFb expression (TGFb, violet: K) and phosphorylated-SMAD2, a marker
downstream of TGF-b signalling (pSMAD2, violet: L, M and N). Cell nuclei (DAPI, blue: K, L and M). Yellow-white areas indicate overlapping
SALB and GFAP immunoreactivity (K, L and M). High magnification ( 40) composite fluorescence image (M) and fluorescence channels (N,
pSMAD2; O, SALB; P, GFAP). Magnification: K and L =  20; M–P =  40. Scale bars in K and L = 100 mm; M–P = 50 mm. Serum albumin
extravasation, GFAP-immunoreactive astrocytosis, and pSMAD2-TGFb upregulation were not observed in the contralateral perirhinal cortex of
IMP mice nor in perirhinal cortex of either hemisphere in CON mice (Supplementary Fig. 4A–F). (Q–V) Focal blood–brain barrier disruption and
co-localizing serum albumin extravasation detected in the brains of living mice by dynamic contrast-enhanced MRI (DCE-MRI) neuroimaging with
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permeability defects were not detected by neuroimaging in
the contralateral cortex of impact-injured mice or either
hemisphere in uninjured control mice. Post-mortem neuropathological examination did not reveal evidence of haemorrhagic contusion, suggesting that the permeability defect
resulted from blood–brain barrier dysfunction rather than
intraparenchymal haemorrhage.
To conﬁrm that the detected neuroimaging abnormalities
represented true blood–brain barrier permeability disruption, we used laser ablation-assisted metallomic imaging
mass spectrometry to map tissue concentrations and spatial
distribution of gadolinium in coronal sections of brains
harvested from impact-injured and control mice. Mice in
both groups received intravenous gadofosveset trisodium
during dynamic neuroimaging (Fig. 5Q–V). Metallomic
imaging mass spectrometry maps of brains obtained from
impact-injured mice revealed enhanced gadolinium accumulation in left perirhinal cortex (Fig. 5V) that co-localized
with the neuroimaging abnormalities (Fig. 5Q–T).
Enhanced gadolinium accumulation was not detected in
contralateral perirhinal cortex of impact-injured mice or
control mice. These results conﬁrm that impact injury
was associated with ipsilateral traumatic microvascular
injury and focal blood–brain barrier disruption in mice
exposed to unilateral closed-head impact injury. Our results
provide ‘proof of concept’ validation of dynamic brain imaging with gadofosveset trisodium for diagnostic evaluation
of blood–brain barrier dysfunction in the acute-subacute
period after closed-head impact injury.
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Relationship of neuroinflammation to traumatic
microvascular injury and early CTE tau pathology
Given the co-localization of three CTE-associated brain
pathologies—phosphorylated tauopathy, traumatic microvascular injury, and blood–brain barrier disruption—after
impact neurotrauma and the known involvement of myeloid-derived cells in tau processing (Asai et al., 2015) and
association with CTE (Cherry et al., 2016), we hypothesized that focal neuroinﬂammatory responses would be
triggered by impact injury. To test this hypothesis, we
used ﬂow cytometry to characterize inﬂammatory cell
phenotypes and time course of neuroinﬂammatory
responses triggered by experimental closed-head impact
injury (Fig. 5W–BB; Supplementary Fig. 4G–I).
We observed a signiﬁcant increase in the number of inﬁltrating peripheral myeloid cells 3 days post-injury in brains
from impact-injured mice (n = 7) compared to controls
(n = 8) [one-way ANOVA, F(5,38) = 3.74, P = 0.0076;
Bonferroni-corrected two-tailed Student’s t-test, P =
0.0054] (Fig. 5W). The Day 3 leucocyte peak coincided
with peak astrocytosis and microgliosis detected by histopathology (Fig. 3H and K). Immunophenotyping analysis
revealed co-expression of molecular markers that identify
these cells as presumptive inﬂammatory monocytes and
brain macrophage derived from inﬂammatory monocytes
(Fig. 5Y) (Murray and Wynn, 2011). Sub-phenotyping
based on monocyte surface antigen expression in impactinjured mouse brains at Day 3 post-injury revealed a signiﬁcant increase in all three functional classes (Fig. 5Z):

Figure 5 Continued
gadofosveset trisodium, an FDA-approved gadolinium-based contrast agent that binds serum albumin. High-field (11.7 T) T1-weighted MRI (Q and
R) and DCE-MRI (S and T) with systemically administered gadofosveset trisodium. T1-weighted MRI and DCE-MRI were conducted 3 h (Q, T1weighted MRI (T1W-MRI); S, DCE-MRI) and 3 days (R, T1-weighted MRI; T, DCE-MRI) after IMP or CON exposure. T1-weighted hyperintensity
(Q and R) co-localized with blood–brain barrier permeability defect detected by DCE-MRI (S and T) in the left perirhinal cortex (arrows) 3 h and
3 days after IMP but not CON exposure. Non-specific signal was observed in the ventricles and sagittal sinus. D = dorsal, V = ventral; L = left,
R = right. (U and V) Confirmation of serum albumin extravasation indicating blood–brain barrier disruption by gadolinium metallomic imaging
mass spectrometry (Gd-MIMS) in perfused post-mortem brains from the same mice imaged by T1-weighted MRI (Q and R) and DCE-MRI (S and
T). Enhanced gadolinium accumulation was observed in the left lateral perirhinal and piriform cortices (arrow) 2 weeks after IMP (V) but not
CON (U) exposure. Gadolinium accumulation detected by Gd-MIMS co-localized with T1-weighted hyperintensity and blood–brain barrier
permeability defect detected by DCE-MRI, thus confirming intracerebral blood–brain barrier disruption. (W–BB) Flow cytometry analysis
showed that IMP triggers increased number of CD45 + inflammatory cells and activation of TREM2 + microglia in the brain post-injury. CD45 +
inflammatory cells (W) and CD45loCD11b + microglia (X) were significantly increased 3 days after IMP compared to CON exposure. (Y)
CD45hiCD11b + Ly –6G – inflammatory cells accumulated in the brain 3 days after IMP compared to CON exposure. (Z) All three major
subpopulations (Ly-6Chi, Ly-6Cmid, Ly-6Clo) were represented in CD45hiCD11b + Ly–6G – inflammatory cells detected 3 days post-injury. (AA and
BB) Upregulation of TREM2 expression in microglia (AA) but not CD45 + inflammatory cells (BB) at 1 and 14 days after IMP compared to CON
exposure. For flow cytometry experiments, n = 6–8 mice per group per time point. ***P 5 0.001; **P 5 0.01; *P 5 0.05. See Supplementary Fig.
4G–I for flow cytometry population dot plots. (CC–HH) Brain accumulation of Ccr2RFP-expressing inflammatory cells (red-labelled cells) and
activation of brain-resident Cx3cr1GFP-expressing microglia (green-labelled cells) were confirmed by fluorescence microscopy in perirhinal cortex
ipsilateral and subjacent to experimental impact injury in Ccr2RFP/Cx3cr1GFP mice at 3 days post-injury (IMP: CC, DD, GG and HH) or control
(CON: EE and FF). Representative fluorescence microscopy images show red-labelled Ccr2RFP-expressing inflammatory cells (arrows, CC)
throughout the ipsilateral (left) perirhinal and adjacent cortex, basolateral amygdala, and overlying dura and leptomeninges (CC and HH) 3 days
post-injury. The affected cortex was also notable for large numbers of ameboid Cx3cr1GFP-expressing microglia (arrowheads; CC and GG) that
were also present, but to a lesser degree, in the contralateral (right) hemisphere (DD). Note clustering of Ccr2RFP-expressing inflammatory cells
and Cx3cr1GFP-expressing microglia in the left perirhinal cortex (dashed circles, CC), the primary locus of post-traumatic brain pathology
ipsilateral and subjacent to the impact. By contrast, Ccr2RFP-expressing inflammatory cells were minimally present and amoeboid Cx3cr1GFPexpressing microglia were absent in brains from Ccr2RFP/Cx3cr1GFP mice 3 days after CON exposure (EE and FF). Bars (CC–FF), 40 microns;
(GG, HH), 20 microns.

440

| BRAIN 2018: 141; 422–458

short-lived inﬂammatory monocytes [one-way ANOVA,
F(1,13) = 17.15, P = 0.0012] (Geissmann et al., 2003); immature monocytes [one-way ANOVA, F(1,12) = 17.73,
P = 0.0005] (Sunderkötter et al., 2004); and patrolling
monocytes [one-way ANOVA, F(1,13) = 16.29, P =
0.0014] (Auffray et al., 2007). Flow cytometry also revealed an apparent expansion of microglia on Day 3
post-injury in brains from impact-injured mice but not control mice [one-way ANOVA, F(5,38) = 4.207, P = 0.0039;
Bonferroni-corrected two-tailed Student’s t-test, P = 0.043]
(Fig. 5X).
We hypothesized that neuroinﬂammatory reactions to
closed-head impact injury would be accompanied by
trauma-stimulated microglial phenotype transformation.
To evaluate this hypothesis, we investigated microglial expression of TREM2 (triggering receptor expressed on myeloid cells 2 protein), an immunoglobulin superfamily cell
surface receptor and homeostatic regulator of cytokine production, phagocytic clearance, innate immunity responses,
and tissue repair (Bhaskar et al., 2010; Kokiko-Cochran
et al., 2016; Ulrich and Holtzman, 2016). TREM2 expression is upregulated in activated microglia (Schmid et al.,
2002; Kawabori et al., 2015; Wang et al., 2015).
Moreover, TREM2 gene variants in human populations
are associated with increased risk of age-related neurodegenerative diseases, including Alzheimer’s disease
(Guerreiro et al., 2013; Jonsson et al., 2013; Phimister
and Tanzi, 2015; Ulrich and Holtzman, 2016). Flow cytometry immunophenotyping revealed a signiﬁcant increase
in the percentage of microglia expressing TREM2 [oneway ANOVA, F(5,38) = 13.14, P 5 0.0001; Bonferronicorrected two-tailed Student’s t-tests: 24 h, P = 0.0072,
Impact n = 8, Control n = 8; 2 weeks, P = 0.0348, Impact
n = 7, Control n = 6] compared to controls (Fig. 5AA).
Notably, activation of microglial TREM2 expression temporally preceded peripheral monocyte inﬁltration in brains
of impact-injured mice. By contrast, we did not detect a
signiﬁcant change in TREM2-expressing inﬁltrating myeloid cells in brains from impact-injured mice compared to
controls at any of the three time points (Fig. 5BB).
To conﬁrm cellular phenotype localization and transformation of brain-resident microglia and presumptive
brain-inﬁltrating monocytes, we crossed geneticallymodiﬁed mice that produce red ﬂuorescent protein-labelled
inﬂammatory monocytes (Ccr2RFP mice) with geneticallymodiﬁed mice that produce green ﬂuorescent proteinlabelled brain-resident microglia and perivascular
macrophages (Cx3cr1GFP mice). F1 progeny expressed red
ﬂuorescent protein-labelled monocytes (red cells) and green
ﬂuorescent protein-labelled brain-resident microglia and
perivascular macrophages (green cells). We subjected
crossed mice to impact injury under the same experimental
conditions used in the preceding experiments. Fluorescence
microscopic analysis of brain sections obtained from these
mice at Day 3 post-injury revealed large numbers of redlabelled monocytes throughout the ipsilateral perirhinal, insular, and piriform cortices and overlying leptomeninges
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subjacent to impact (Fig. 5CC and HH). Presumptive inﬁltrating monocytes co-localized with large ameboid-shaped
microglia and perivascular macrophages (Nayak et al.,
2014) (Fig. 5CC and GG). Presumptive red-labelled inﬁltrating monocytes and green-labelled ameboid-shaped
microglia and macrophages were also present but far
more scarce in the contralateral (right) hemisphere at Day
3 post-injury (Fig. 5DD). By contrast, presumptive inﬁltrating monocytes were minimally present and co-localizing
ameboid-shaped microglia and macrophages were absent
in brains from uninjured control mice (Fig. 5EE–FF).

Unilateral impact injury induces bilateral
electrophysiological deficits in hippocampus and
prefrontal cortex
Given the known clinical association of mild TBI with cognitive impairment and executive dysfunction (Evans, 2006;
Ropper and Gorson, 2007; Alosco et al., 2017), and recent
recognition of concordant abnormalities in early-stage CTE
(i.e. traumatic encephalopathy syndrome; Montenigro
et al., 2014, 2017), we hypothesized that experimental
head injury could disrupt neurophysiological function in
two critical brain regions subserving these functions,
namely, the hippocampus and medial prefrontal cortex
(McDonald et al., 2002; Sigurdsson and Duvarci, 2015;
Place et al., 2016). To test this hypothesis, we evaluated
axonal conduction velocity of hippocampal pyramidal cell
compound action potentials in the stratum alveus (Fig. 6A–
D and Supplementary Fig. 5A) and activity-dependent LTP
of synaptic transmission at excitatory inputs to pyramidal
neurons in the medial prefrontal cortex (Fig. 6E–J and
Supplementary Fig. 5B–D). Analysis of hippocampal pyramidal cell compound action potentials (Fig. 6A) revealed
signiﬁcant and persistent decrements in axonal conduction
velocity in the ipsilateral (left) hippocampus at 24 h, 3 days,
and 2 weeks post-injury (Fig. 6B–D). Three-way ANOVA
[main factors: injury (levels: TBI and control), post-injury
interval (levels: 24 h, 3 days, and 2 weeks), and side (levels:
ipsilateral and contralateral to impact)] revealed a signiﬁcant effect for injury [F(1,119) = 71.431; P 5 0.0001] on
axonal conductance, with comparable decrements in hippocampus ipsilateral and contralateral to impact 24 h, 3 days,
and 2 weeks post-injury (Fig. 6B and C). There was no
signiﬁcant
effect
for
either
post-TBI
interval
[F(2,119) = 0.212; P = 0.8094] or brain hemisphere
[F(1,119) = 0.033; P = 0.8554]. While axonal conduction
velocity in the right (contralateral) hippocampus returned
to baseline levels by 2 weeks post-injury, axonal conduction velocity in the left (ipsilateral) hippocampus remained
impaired at this time point (Fig. 6D).
Given the impact-induced functional impairments in hippocampal axonal conduction velocity, we examined the
effect of impact injury on synaptic transmission and stimulus-evoked LTP of synaptic strength at excitatory inputs to
pyramidal neurons in the medial prefrontal cortex
(Supplementary Fig. 5B and C). The rationale for this investigation is based on neuroanatomical and functional
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connections between the hippocampus and medial prefrontal cortex, and additionally, the prominence of executive dysfunction (mediated, in part, by the medial
prefrontal cortex) that commonly accompanies closedhead impact injuries in humans (see ‘Discussion’ section).
Analysis of white matter-evoked postsynaptic ﬁeld potential
input-output relations indicated that impact injury did not
alter baseline synaptic transmission (Supplementary Fig.
5D). However, left-lateral impact induced signiﬁcant and
persistent bilateral decrements in stimulus-evoked LTP in
the medial prefrontal cortex at 24 h, 3 days, and 2 weeks
post-injury (Figs. 6E–J). Three-way ANOVA (main factors
and levels as above) determined that only injury had a
signiﬁcant effect on LTP in the medial prefrontal cortex
[F(1,60) = 60.227; P 5 0.0001], with no effect of either
post-TBI interval [F(2,60) = 0.029; P = 0.9761] or recording
side [F(1,60) = 0.949; P = 0.3340], and no interaction of
main factors. Moreover, the magnitude of post-tetanic potentiation immediately after application of theta-burst
stimulation was also reduced at all three time points.
Together, these results indicate that exposure to unilateral
closed-head impact injury induces acute, persistent, and
bilateral impairments in hippocampal axonal conduction
velocity and disruption of short- and long-term activitydependent synaptic plasticity in the medial prefrontal
cortex.

Acute neurobehavioural responses to closed-head
impact injury do not correlate with TBI and CTE
endpoints
Recent clinical ﬁndings suggest that cumulative concussion
exposure correlates poorly with post-traumatic brain
pathologies and functional sequelae (Breedlove et al.,
2012; Davenport et al., 2014; Talavage et al., 2014;
Abbas et al., 2015; Montenigro et al., 2017). Moreover,
post-mortem studies have conﬁrmed that a subset (20%)
of former athletes with neuropathologically-veriﬁed CTE
did not have a history of concussion (Bieniek et al.,
2015; Stein et al., 2015a). Our experimental results
allowed us to evaluate the putative relationship between
concussion and CTE brain pathology by testing for possible correlations between composite scores on the acute
neurobehavioural response test battery and quantitative
endpoints associated with TBI and early CTE
(Supplementary Table 3). Target metrics included blood–
brain barrier disruption by Evans blue-speciﬁc ﬂuorescence, neuroinﬂammation assessed by myeloid cell ﬂow
cytometry, phosphorylated tau proteinopathy by quantitative immunoblot analysis, impaired hippocampal axonal
conduction velocity, and defective LTP in the medial prefrontal cortex. Time point selection was based on peak
post-injury responses for each TBI and CTE metric.
Consistent with clinical (Breedlove et al., 2012;
Davenport et al., 2014; Talavage et al., 2014; Abbas
et al., 2015; Montenigro et al., 2017) and pathological
ﬁndings in humans (Bieniek et al., 2015; Stein et al.,
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2015a), we did not detect any statistically signiﬁcant correlation between test battery composite scores and quantitative endpoints associated with TBI and early CTE
(Supplementary Table 3).
Based on these results, we hypothesized that the mechanisms underpinning concussion-like deﬁcits after experimental impact injury may be independent of the mechanisms
that drive TBI and CTE brain pathologies. We investigated
the mechanistic underpinnings of this hypothesis in the following section.

Head impact and blast exposure
induce different force loading, shear
stress, and concussion-like deficits
The brain pathologies and functional sequelae observed
after experimental impact injury are generally consistent
with corresponding responses following blast exposure
(Goldstein et al., 2012; Huber et al., 2013; Kondo et al.,
2015). While the manner in which kinetic energy is transferred to the head is different in the two types of insult, the
brain pathologies associated with each are similar in laboratory animals and humans (Omalu et al., 2011;
Goldstein et al., 2012; Huber et al., 2013; McKee et al.,
2013; Kondo et al., 2015; Shively et al., 2016; Mez et al.,
2017). Concordance of head motion in our impact and
blast mouse models enabled comparative evaluation of
acute neurobehavioural responses, structural brain pathologies, and functional sequelae produced by these two biomechanically different neurotrauma mechanisms under
exposure conditions matched for head kinematics
(Supplementary Table 2).
We subjected awake, anaesthesia-naı̈ve C57BL/6 male
mice to experimental closed-head impact injury (n = 203)
or blast exposure (n = 24) under conditions that produce
comparable head kinematics and evaluated mice after exposure using the acute neurobehavioural responses test battery (Fig. 7A). Baseline (pre-injury) testing showed that
mice in both groups exhibited indistinguishable mean composite test battery scores (mean  SEM: impact, 14.9  0.0;
blast, 14.8  0.1; linear mixed-effects regression analysis,
P 4 0.05). While impact-injured mice demonstrated the expected signiﬁcant decrement in post-injury composite scores
(mean  SEM: 11.6  0.2; linear mixed-effects regression
analysis, P 5 0.0001; Supplementary Video 1), blastexposed mice did not (mean  SEM: 14.5  0.1; linear
mixed-effects regression analysis, P 4 0.05; Supplementary
Video 1). This result was robust, reliable, and entirely unexpected, especially given comparable head kinematics in
the two models. It is worth noting that the absence of
acute neurobehavioural deﬁcits following blast exposure
comports with the low incidence of concussion after pure
blast exposure in the absence of concomitant contact injury
(Barrow and Rhoads, 1944; Luethcke et al., 2011). After 3h recovery, both experimental groups again demonstrated
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Figure 6 Unilateral closed-head impact injury induces early, persistent, bilateral impairments in hippocampal axonal conduction velocity and medial prefrontal cortical long-term potentiation of synaptic neurotransmission. (A–D) Time course of
impaired axonal conduction velocity in the hippocampus (HIPP) CA1 subregion of mice exposed to unilateral (left-sided) closed-head impact
injury (IMP, red) or sham (no injury) control (CON, black). Time points: 24 h, 3 days, 2 weeks post-exposure. Experimental testing arrangement in
relation to neuroanatomy and circuitry is shown in Supplementary Fig. 5A. (A) Representative stimulus-evoked compound action potentials at
proximal (solid lines) and distal (dashed lines) recording sites in the CA1 subregion of hippocampus slices obtained from mice exposed to

(continued)
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indistinguishable mean composite test battery scores that
were also indistinguishable from baseline scores
(mean  SEM: impact, 14.7  0.0; blast, 14.5  0.1;
linear mixed-effects regression analysis, P 4 0.05). Given
that head motion in the two experimental models was kinematically comparable, our observation of decrements in test
battery composite scores after impact injury but not after
blast exposure argues against head motion per se as a primary causative mechanism that differentiates concussionlike neurobehavioural responses after these insults.
To investigate the origins of this unexpected difference,
we constructed mouse headforms to which we attached
pressure-sensitive ﬁlm on the lateral surface. Impact and
blast exposures were conducted as above. Force loading
was assessed by determining total pixel intensity registered
by the pressure-sensitive ﬁlm (Fig. 7B). Total pixel intensity
on ﬁlm exposed to impact was signiﬁcantly greater than for
blast (mean  SEM, n = 5: impact, 6.49  0.43  106 a.u.;
blast, 0.28  0.04  106 a.u.; Bonferroni-corrected onetailed Student’s t-test, P = 0.0002) while both impact and
blast generated signiﬁcantly greater pixel intensities than
respective controls (mean  SEM, n = 5: impact control,
1.58  0.66  104 a.u.; blast control, 2.67  0.51 
104 a.u.; Bonferroni-corrected one-tailed Student’s t-tests:
impact versus impact control, P = 0.0002; blast versus
blast control, P = 0.0089). Moreover, impact produced
high pressure loading that was restricted to the contact
zone, whereas blast generated far lower pressure that was
evenly distributed within the measurement area (Fig. 7B).
These results point to fundamentally different energy loading regimes at the moment of traumatic contact.
Experimental methods are not currently available to
measure stresses in discrete regions of the living mouse
brain at microsecond time resolution. Thus, we investigated
how these results relate to the observed differences in acute
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neurobehavioural responses to impact injury and blast exposure by using dynamic computational simulations of our
two experimental mouse models. We used the ArbitraryLagrangian-Eulerian hydrostructural ﬁnite element code
ALE3D (Noble et al., 2017) developed at the Lawrence
Livermore National Laboratory to simulate the experimental impact instrument described above and blast tube used
here and in previous studies (Goldstein et al., 2012; Kondo
et al., 2015). We simpliﬁed the computational analysis by
assuming a spherical mouse head consisting of a 0.2 mm
thick skull, 0.2 mm subdural layer (with CSF), and a
10 mm diameter brain (Fig. 7C). Initial conditions were
set such that the resulting centre-of-geometry motions
were similar to each other and representative of empirically-derived experimental data in both animal models. Since
the spherical mouse head model excluded mass external to
the skull, it was necessary to proportionally scale the
impact rod velocity to produce head motion that matched
peak head acceleration calculated for blast. Skull deﬂection
during impact was 19.8 mm (50.2% of the skull diameter)
consistent with an absence of skull fracture or signiﬁcant
skull deformation in our closed-head impact injury mouse
model. The close agreement of the simulation results with
empirically-derived head kinematic data obtained in living
mice provided validation for the computational methods
used in the computational comparisons below. Peak accelerations and calculated head injury criterion (HIC) provided further conﬁrmation of the kinematic similarity of
the impact and blast simulations (Fig. 7C and D).
While head accelerations were closely approximated in
the two simulations (Fig. 7D), calculated overpressures in
the brain were larger at each of three intracerebral
Lagrangian tracer locations during blast exposure than
during impact injury (Supplementary Fig. 6A and B). If
increased pressure were the dominant factor responsible

Figure 6 Continued
unilateral impact (IMP, red) versus sham (no-injury) control mice (CON, black). Arrows indicate peak negativities used to calculate conduction
velocity. (B) Conduction velocity measurements from first peak compound action potential delay as a function of distance between recording
electrodes in CA1 pyramidal cell axons in the stratum alveus of hippocampus slices from mice subjected to unilateral left-sided IMP (red bars: left,
n = 9, right n = 10) compared to CON (black bars: left, n = 10; right, n = 7) 24 h post-exposure. Each bar is mean axonal conduction
velocity  SEM of n slices. **P 5 0.01. (C) Conduction velocity measurements in CA1 pyramidal cell axons in stratum alveus of hippocampus
slices from mice subjected to unilateral left-sided IMP (red bars: left, n = 14; right, n = 16) compared to CON (black bars: left n = 7; right, n = 9) 3
days post-exposure. **P 5 0.01; *P 5 0.05. (D) Axonal conduction velocity measurements in CA1 pyramidal cell axons in the stratum alveus of
hippocampus slices from mice subjected to unilateral IMP (red bars: left, n = 16; right, n = 12) compared to CON (black bars; left, n = 7; right,
n = 8) 2 weeks post-exposure. *P 5 0.05. (E–J) Impaired theta burst-evoked long-term potentiation (LTP) of mixed excitatory inputs to the
medial prefrontal cortex (mPFC) in slices from mice after unilateral (left-sided) closed-head impact injury (IMP, filled red circle) compared to sham
(no injury) control condition (CON, filled black circle). LTP calculated as ratio of field excitatory postsynaptic potential (fEPSP) slope at time
points T1/T2 (vertical grey bands). Theta burst high-frequency stimulation, arrows. Each point is mean  SEM of fEPSP slope in N slices. (E) Time
course of LTP in left (ipsilateral) mPFC from mice 24 h after exposure to left-lateral IMP (filled red circle, n = 7) or CON (filled black circle, n = 7).
(F) Time course of LTP in right (contralateral) mPFC from mice 24 h after exposure to left-lateral IMP (filled red circle, n = 8) or CON (filled black
circles, n = 6). (G) Time course of LTP in left (ipsilateral) mPFC from mice 3 days after exposure to left-lateral IMP (filled red circles, n = 11) or
CON (filled black circles, n = 8). (H) Time course of LTP in right (contralateral) mPFC from mice 3 day after exposure to left-lateral IMP (filled
red circles, n = 10) or CON (filled black circles, n = 8). (I) Time course of LTP in left (ipsilateral) mPFC from mice 2 weeks day after exposure to
left-lateral IMP (filled red circles, n = 9) or CON (filled black circles, n = 6). (J) Time course of LTP in right (contralateral) mPFC from mice 2
weeks day after exposure to left-lateral IMP (filled red circles, n = 10) or CON (filled black circles, n = 6). White matter-evoked synaptic field
potential input-output relations were not affected by experimental impact injury (Supplementary Fig. 5D).
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Figure 7 Differential force loading on the head and ipsilateral shear stress in the brain differentiate the presence or absence of
acute concussion-like neurobehavioural deficits after unilateral closed-head impact injury or blast exposure. (A) Mean composite
scores on the acute neurobehavioural response test battery in awake, unanaesthetized (anaesthesia-naı̈ve) mice 2 min after unilateral closed-head
impact injury (red bars; n = 203) or blast exposure (blue bars; n = 24) under experimental conditions matched for comparable head kinematics
(Supplementary Table 2). Unilateral closed-head impact triggered abrupt onset of transient neurobehavioural deficits (Supplementary Video 1).
Impact-induced decrements in mean test battery composite scores recovered to baseline when tested after 3-h recovery period. By contrast,
blast exposure under conditions that produce comparable head motion did not induce decrements in mean composite scores on the postexposure test battery. Mean composite scores  SEM. ***P 5 0.001, linear mixed-effects regression analysis. (B) Evaluation of force loading
regimes during impact injury (red bar) compared to blast exposure (blue bar) at the surface of a mouse headform. Experimental conditions were
identical to those utilized in the live animal experiments. Representative images of pressure-sensitive film strips (black boxes, above) after
exposure to impact (left) or blast (right) with corresponding pixel intensity histograms (below). Large green boxes indicate pressure signal
summation areas. Inset boxes show magnified view of the summation area and reveal differences in the spatial distribution of the pressure signals.
Mean sum of pixel values  SEM in arbitrary units (a.u.). ***P 5 0.001, one-tailed Student’s t-test. (C) Material densities and head geometry used
in the computational simulation analyses and resulting kinematics. (D) Computational simulations showing comparable head kinematics and peak
acceleration at the centre of the brain in the impact and blast simulation models. Arrows, corresponding peak head x-acceleration for impact (red)
and blast (blue) models. Kinematic results for the models were statistically indistinguishable. The small initial negative deflection on the blast
simulation is a filtering artefact. (E and F) Simulation results showing intracranial shear (von Mises) stress and extracranial overpressure during
impact (E, slice of three-dimensional simulation) and blast (F, slice of two-dimensional simulation) exposure at peak head x-acceleration time
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for the observed differences in acute neurobehavioural responses to impact injury compared to blast exposure, then
we would expect blast-exposed mice to preferentially exhibit greater impairment than impact-injured mice. Our experimental results indicated the opposite effect (Fig. 7A).
This result indicates that intracranial pressure is not likely
to be a primary physical driver of differential concussionlike responses that occur after impact injury but not after
blast exposure. As an alternative hypothesis, we postulated
that intraparenchymal shear stress could differentiate
impact and blast with respect to the observed differences
in acute neurobehavioural responses. Selected computational solutions at peak head acceleration are shown as
spatially-mapped numerical values of the von Mises stress
(a measure of shear stress) in the skull, CSF, and brain
along with coincident overpressure in the padding for
impact and overpressure in the air surrounding the head
for blast (Fig. 7E and F). The magnitude and temporal
evolution of shear stress in the head (skull, CSF, brain) is
shown at time of contact, at peak head acceleration, and
150 ms after peak head acceleration in both simulations
(Fig. 7G and H) and as time histories at each of the
three selected intracerebral Lagrangian tracer locations
(Fig. 7I and J). The temporal history of stress dynamics
in the impact and blast simulation models are shown in
Supplementary Video 2.
The impact simulation model revealed a large area of
relatively sustained high peak shear stress that localized
within a discrete brain region ipsilateral and subjacent to
the impact contact zone (Fig. 7E). By contrast, the blast
simulation demonstrated modest and relatively brief peak
shear stress that was limited to a small area in the contralateral region of the brain on the leeward side of head
(Fig. 7F). The relatively minor shear stress resulting from
blast coalesced 25 ms after the blast reached the skull and
dissipated 85 ms later (total duration, 60 ms).
Representative time histories of the von Mises stress at selected tracer points in the model head showed that impact
produced 7-fold greater peak shear stress compared to blast
(Figs. 7I–J). Moreover, impact-induced shear stress
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exhibited strong spatial dependence with peak magnitude
in the ipsilateral brain subjacent to the impact contact zone.
Importantly, peak shear stress triggered by impact occurred
0.25 ms after contact (centre of mass motion 4 300 mm)
and before onset of gross head motion. These simulations
(Fig. 7E–J) show that spatially and temporally localized
shear stress in impact and absence in blast result from differences in focal loading and the low shear modulus of the
brain.
These computational results are consistent with our observation of acute onset of transient neurobehavioural deficits across multiple functional domains in mice subjected
to experimental impact injury but not after blast exposure
under conditions matched for head kinematics (Fig. 7A).
The impact simulation results are also consistent with experimental observations of abrupt onset of right-sided
motor weakness and incoordination after left-sided impact
injury. These results are also concordant with neuropathological evidence demonstrating that unilateral closed-head
impact injury in our mouse model produces acute-subacute
brain pathology that localizes predominantly in cerebral
cortex and neighbouring brain regions (e.g. basolateral
amygdala) ipsilateral and subjacent to the head impact contact zone.

Discussion
We examined post-mortem brains obtained from teenage contact sport athletes who died in the acute-subacute period
(1 day–4 months) after closed-head impact injuries and compared results to control brains from an age-matched control
cohort of contact sport athletes without recent head injuries.
Neuropathological analysis revealed a spectrum of post-traumatic pathologies, including astrocytosis, axonopathy, microvasculopathy, neuroinﬂammation, and phosphorylated
tauopathy. The presence of haemosiderin-laden macrophage, reactive astrogliosis, and perivascular microgliosis is
consistent with traumatic microvascular injury, blood–brain
barrier disruption, and secondary neuroinﬂammation
(Cherry et al., 2016; Jullienne et al., 2016; Kenney et al.,

Figure 7 Continued
points indicated by arrows in D. Computed extracranial overpressure measurements at peak head acceleration are shown calibrated to scale
(light-dark blue scale; kPa) for the foam padding (impact model) and ambient air (blast model). Computed shear (von Mises) stresses in the skull,
CSF, and brain parenchyma at peak head x-acceleration are shown calibrated to scale (yellow–red scale; Pa) for both simulation models.
Intracranial Lagrangian tracers: C = contralateral with respect to impact or blast contact surface on the head; I = ipsilateral; M = midline. Insets:
relationship of intracranial compartments in the mouse head simulation models. (G and H) Representative time sequence frames (t1: contact, t2:
peak head x-acceleration, t3: 150 ms after peak head x-acceleration) for intracranial shear (von Mises) stress and extracranial overpressure
(padding, ambient air) in the impact (G) and blast (H) simulations. Impact induces focal point loading on the head and 7-fold greater magnitude
shear stress in the brain that localizes to (and persists in) a discrete region of brain ipsilateral and subjacent to the impact contact zone. Sustained
asymmetric shear stress in the simulation recapitulates the ipsilateral locus of post-traumatic brain pathology observed in the animal experiments.
Note that impact produces peak shear stress in the brain before onset of gross motion of the head. By contrast, blast exposure under conditions
that induces comparable head kinematics results in distributed loading on the head and lower magnitude shear stress in the brain. (I and J) Time
dependence of the intracranial shear stress for impact (I) and blast (J) simulation models at the ipsilateral, midline, and contralateral Lagrangian
tracer locations. Full-sequence computational simulation time histories for impact and blast are available for viewing (Supplementary Video 2).
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2016; McKee et al., 2016). Notably, two of four brains
showed evidence of phosphorylated tauopathy and one case
qualiﬁed for neuropathological diagnosis of early stage CTE
(McKee et al., 2016). Clinicopathological correlation suggested mechanistically causal linkage between early CTE
brain pathologies, including phosphorylated tauopathy, and
antecedent closed-head impact injury (Goldstein et al., 2012;
McKee et al., 2013; Kondo et al., 2015; Kenney et al., 2016).
Few published case series have investigated brain pathology in individuals who have sustained mild forms of
closed-head impact injury and died in the acute-subacute
period post-injury (Oppenheimer, 1968; Blumbergs et al.,
1994; McKee et al., 2014). Limitations pertinent to these
studies and ours include: (i) small number of cases; (ii) variation in mechanics, severity, and timing of head injury; (iii)
potential confounds associated with comorbidities, history
of prior neurotrauma, and genetic and medical risk factors;
(iv) duration and circumstances of the agonal period and
post-mortem interval; (v) incomplete case information; (vi)
adequacy of control brains; (vii) methodological and technical issues; (viii) exclusive male sex bias (this study); and
(ix) inherent limitations of clinicopathological correlation
to establish mechanistic causality (Goldstein et al., 2014;
Wojnarowicz et al., 2017).
Caveats notwithstanding, these case reports are highly
informative. Oppenheimer (1968) observed perivascular
microglia and astrocytes in proximity to petechial and
capillary haemorrhages as early as 15 h post-injury
(Oppenheimer, 1968). Blumbergs et al. (1994) reported
post-traumatic axonopathy 2–99 days after mild concussive
head injury. The neuropathologies that we observed in
young athletes in the acute-subacute period after closedhead impact injury included axonopathy, microvascular
disruption, and perivascular neuroinﬂammation are consistent with the earlier reports. To this triad we highlight a
fourth element, phosphorylated tauopathy (Goldstein et al.,
2012; McKee et al., 2014). In the cases reported here, we
detected pathogenic accumulation of phosphorylated tau
protein accumulation in brains of two of four acute-subacute head injury cases, one of which met diagnostic criteria for early-stage CTE.
Clearly, not every individual who sustains a head injury,
even if repeated, will develop CTE brain pathology. While
clinicopathological correlation in our case series suggests
that closed-head impact injury can trigger early brain
pathologies associated with CTE, the causal mechanisms,
temporal relationships, and contextual circumstances that
link speciﬁc brain pathology to a particular antemortem
insult are impossible to ascertain with certainty based
solely on post-mortem neuropathology. This point is germane to the ﬁndings reported here given the documented
head injury exposure histories of the decedents. Rather, the
critical question addressed in this study is whether or not
antecedent head injury per se is sufﬁcient to causally induce
(mechanistically determine) early CTE brain pathologies.
To investigate hypothesized causal connections between
impact injury and early CTE pathology, we developed a
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mouse model of closed-head impact injury that uses momentum transfer to produce traumatic head acceleration
without gross skull deformation. The developed impact
mouse model is notable for matching head kinematics in
our previously published blast neurotrauma mouse model
(Goldstein et al., 2012; Kondo et al., 2015).
Unanaesthetized (anaesthesia-naı̈ve) mice subjected to unilateral closed-head impact, but not experimental blast
exposure, exhibited abrupt onset of transient neurobehavioural deﬁcits with rapid and complete spontaneous resolution. The observed deﬁcits, temporal course, and rapid
recovery constitute an experimental concussion-like syndrome with phenomenological resemblance to human concussion (Supplementary Video 1). We used the acute
neurobehavioural response test battery to objectively evaluate these transient neurobehavioural deﬁcits. It is important
to note that test battery composite and subtest scores capture integrated neurobehavioural performance that includes
neuromotor function (strength and coordination of proximal, distal, and axial muscle groups), gait and balance,
locomotion, exploratory drive, arousal level, responsivity
to environmental stimuli, orientation behaviour, thigmotaxis, anxiety-neophobia, and habituation, amongst others
(Walsh and Cummins, 1976; Brooks and Dunnett, 2009;
Sukoff Rizzo and Crawley, 2017). Interestingly, we
noted variation in the sensitivity of the subtests to discriminate neurobehavioural impairment post-injury (i.e. open
ﬁeld  inverted mesh 4 beam walk). This ﬁnding may
prove useful in teasing out speciﬁc substrates, mechanisms,
and pathways underpinning particular concussive signs. We
also noted that left-lateral impact invariably produced
transient right-sided (contralateral) neuromotor deﬁcits,
a ﬁnding consistent with hemispheric cross-lateralization
of cortical motor control. Furthermore, abrupt onset of
deﬁcits was invariably followed by rapid and complete
neurological recovery that began within minutes after
injury. We did not observe persistent gross neurological
impairment, post-traumatic apnoea, skull fracture, status
epilepticus, cervical trauma, or spinal cord injury in any
of the more than 200 impact-injured mice used in this
study.
Given the absence of correlation between composite
scores on the test battery and TBI and CTE endpoints,
our results point to a disturbance of brain function (as
opposed to structural lesions) as the aetiological origin of
the concussion-like neurobehavioural deﬁcits that we
observed after impact injury. Our ﬁndings indicate that,
while impact injury and blast exposure elicit similar longterm neuropathology and sequelae, these insults starkly differentiate the concussion-like syndrome produced by the
former (impact), but not the latter (blast).
Several points deserve emphasis. First, the test battery
provides gross assessment of integrated neurobehavioural
performance across functional domains, including arousal,
anxiety-neophobia, stimulus responsivity, exploratory
drive, locomotion, gait and balance, muscle strength, and
neuromotor coordination (Walsh and Cummins, 1976;
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Suarez and Gallup, 1981; Crawley, 1999; Brooks and
Dunnett, 2009). When deployed with repeated testing as
here, the test battery reliably elicits habituation, a simple
learning response that relies on recent memory (Walsh and
Cummins, 1976; Crawley, 1999). Second, the neurological
deﬁcits that we observed post-injury model clinical features
of concussion in humans (Supplementary Video 1). This
similarity was underscored by phenomenological similarities with respect to the abrupt onset, temporal progression,
transient course, and rapid resolution of acute deﬁcits following impact. Third, despite tight control of the experimental injury (Supplementary Table 2), we observed wide
individual variation in test battery scores. Moreover, variation in the severity of acute responses did not correlate
with impact intensity. Thus, sled velocity (between 3.75 m/s
and 6.25 m/s) did not signiﬁcantly correlate with test battery composite scores (Spearman r = 0.16, P = 0.025,
n = 203). This ﬁnding supports ﬁndings in human athletes
that show wide variation in acute neurological responses
following sports-related head injuries (McCaffrey et al.,
2007; Broglio et al., 2010; Guskiewicz and Mihalik,
2011; Post and Hoshizaki, 2012). Fourth, we observed further signiﬁcant decrement in composite scores after second
impact (Fig. 2D) that showed signiﬁcant positive correlation with composite scores after ﬁrst impact (Spearman
r = 0.52, P 5 0.0001, n = 203). These results are consistent
with reports in human athletes that show increased injury
susceptibility, severity, and sequelae after an index head
injury (Laurer et al., 2001; Prins et al., 2013; Terwilliger
et al., 2016).
Microscopic examination of brains from impact-injured
mice revealed evidence of focal microvasculopathy, blood–
brain barrier disruption, serum albumin extravasation,
astrocytosis, and reactive microgliosis. Flow cytometry
showed that post-traumatic neuroinﬂammation featured activation of TREM2 + expression in brain-resident microglia
and presumptive inﬁltration of monocytes consistent with
recent experimental evidence of similar TREM2 activation
after open-skull cavitating TBI (Saber et al., 2016). That we
detected a similar pattern of neuroinﬂammation stimulated
by far milder closed-head impact injury suggests that
common and persistent response pathways may be triggered across the brain injury spectrum. This point is underscored by a recent case study of repetitive head injuries on
the mild end of the spectrum (Cherry et al., 2016) and
comparison to more severe brain injury cases reported by
Strich (1956, 1961, 1970) and others (Gentleman et al.,
2004; Johnson et al., 2013a; Smith et al., 2013a; Cherry
et al., 2016).
Our results point to possible involvement of TREM2mediated microglial activation. TREM2 binds apolipoprotein E (Atagi et al., 2015) and also membrane lipids (Wang
et al., 2015), suggesting that this microglial receptor may
act as a surface sensor of damaged cell membranes
(Kleinberger et al., 2014; Phimister and Tanzi, 2015;
Ulrich and Holtzman, 2016). Signiﬁcantly, the R47H
mutant TREM2 protein shows reduced binding to both
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ligands (Atagi et al., 2015; Wang et al., 2015) and is associated with elevated risk of Alzheimer’s disease (Guerreiro
et al., 2013; Jonsson et al., 2013). In our study, mice subjected to experimental impact showed dramatic microglia
phenotypic transformation and co-localizing accumulation
of inﬂammatory cells in the ipsilateral perirhinal cortex and
adjacent brain regions subjacent to the impact contact zone
(cf. Russo and McGavern, 2016). Recent evidence indicates
that microglial activation and exosomal processing are critical for spreading tauopathy (Asai et al., 2015). Moreover,
activated microglia induce a subset of reactive astrocytes
that promote neurodegeneration (Liddelow et al., 2017).
Consistent with these ﬁndings, we observed early, persistent, and progressive cis-p-tauopathy that was initially detectable only in axons of the ipsilateral perirhinal cortex
and later in axons, soma, and dendrites in cerebral cortex
in both hemispheres, including sites distant from the primary injury.
Our results comport with recent experiments that point
to somatodendritic miscompartmentalization as a driver
of extracellular tau release and transynaptic propagation
(Wu et al., 2016). Remarkably, we detected cis-ptauopathy bilaterally in cerebral cortex 5.5 months after
unilateral impact. Moreover, tau proteinopathy detected
at this remote time point was present not only at the
primary locus of acute brain injury, but also at distant
sites in both hemispheres of the brain. The origin and
evolution of this tau pathology and relationship to the
inciting injury are as yet undetermined, but may include nucleation-dependent aggregation, seed-dependent
aggregation,
and
prion-like
transcellular
spread
(Clavaguera et al., 2009; Jucker and Walker, 2013;
Goedert, 2015; Woerman et al., 2016; Goedert et al.,
2017).
It is notable that we did not observe mature neuroﬁbrillary tangles in brains from impact-injured mice at any time
point post-injury. This ﬁnding is consistent with other studies conducted in non-transgenic mice that express murine
tau protein (Goldstein et al., 2012; Huber et al., 2013;
Mannix et al., 2013; Petraglia et al., 2014; Kondo et al.,
2015). This discordance may reﬂect incomplete phenotypic
expression (forme fruste) resulting from the high solubility
and aggregation resistance of native murine tau protein, or
alternatively, protracted time dependencies beyond the experimental design of the present studies. Nevertheless, phosphorylated tau proteoforms, especially cis-p-tau as reported
here, are potent drivers of microtubule disruption, mitochondrial dysfunction, spreading tauopathy, and neurodegeneration in laboratory animals and humans (Nakamura
et al., 2012; Kondo et al., 2015; Lu et al., 2016). Early
accumulation, somatodendritic miscompartmentalization,
and persistence of cis-p-tau suggest that aberrant accumulation of this (and likely other) pathogenic phosphorylated tau
species may represent the earliest antecedent pathology of
CTE.
CTE neuropathology is deﬁned by perivascular accumulation of phosphorylated tau protein in the depths of
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cortical sulci (McKee et al., 2016). The perivascular localization of these pathognomonic lesions suggests microvascular dysfunction as a likely contributor to CTE
pathogenesis (Fig. 8). Extravasated serum albumin in the
brain is a known activator of inﬂammatory TGFb signalling, reactive astrocytosis, and neuronal dysfunction
(Heinemann et al., 2012; Weissberg et al., 2015).
Traumatic microvasculopathy in this study was accompanied by blood–brain barrier dysfunction and serum albumin extravasation (Fig. 8B). Serum albumin potently
stimulates astrocytic uptake and phosphorylation of
Smad2/3, a transcriptional co-regulator of inﬂammatory
TGFb signalling (Bar-Klein et al., 2014; Cheslow and
Alvarez, 2016), aberrant neuroglial communication
(David et al., 2009), abnormal dendritic branching
(Tomkins et al., 2007), reduced GABAergic inhibition,
and impaired neuronal plasticity (Lippmann et al., 2017).
That extravasated serum albumin co-localized with reactive
astrocytosis is consistent with activation of this injury response pathway and suggests plausible targets for therapeutic intervention that are now under investigation.
This same pathway affords potential as a diagnostic neuroimaging marker for traumatic microvascular injury, an
understudied TBI endophenotype. We combined dynamic
contrast-enhanced brain imaging (Veksler et al., 2014;
Weissberg et al., 2014) with systemic administration of
gadofosveset trisodium, a gadolinium-containing contrast
agent that binds serum albumin (Richardson et al., 2015),
to detect blood–brain barrier disruption in living mice. TBIinduced gadofosveset accumulated in ipsilateral perirhinal
cortex and co-localized with T1-weighted hyperintensities
and blood–brain barrier permeability defects that we conﬁrmed by metallomic imaging mass spectrometry brain
mapping.
Collectively, our neuropathological and ultrastructural
ﬁndings are consistent with impact-induced microvascular
dysfunction rather than traumatic intraparenchymal haemorrhage. Blood–brain barrier disruption is associated with
neuronal glutamate release (Vazana et al., 2016), pericyte
degeneration (Bell et al., 2010), astrocytic end-feet swelling
and capillary retraction (Ito et al., 2011; Goldstein et al.,
2012). These factors promote blood–brain barrier compromise, local hypoxia, perivascular neuroinﬂammation,
synaptic dysfunction, and neurodegeneration (Barkhoudarian et al., 2016) (Fig. 8B). Our results not only provide
supportive evidence for blood–brain barrier disruption as a
clinically-relevant post-traumatic endophenotype (Hay
et al., 2015; Doherty et al., 2016; Kenney et al., 2016),
but also serve as justiﬁcation for clinical evaluation of dynamic neuroimaging with gadofosveset as a novel diagnostic test for traumatic microvascular injury and presumptive
risk factor test for CTE.
We were surprised that unilateral impact was accompanied by persistent bilateral impairments in hippocampal
axonal conduction and medial prefrontal cortical synaptic
plasticity. These ﬁndings represent post-traumatic functional sequelae that comport with experimental and clinical
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evidence indicating neurophysiological abnormalities in
athletes and laboratory animals in the acute-subacute
period after closed-head impact injuries (Goldstein et al.,
2012; De Beaumont et al., 2013; Namjoshi et al., 2014;
Kondo et al., 2015; Major et al., 2015). Loss of white
matter structural and functional integrity has been reported
in patients following closed-head impact injury (Blennow
et al., 2012; Shenton et al., 2012; Johnson et al., 2013a).
These effects may be mediated by direct axonal injury
(Strich, 1961; Adams et al., 1982; Gennarelli et al., 1982;
Povlishock and Christman, 1995), Wallerian degeneration,
axonal transport dysfunction, post-traumatic demyelination, microvascular injury, pathogenic phosphorylated
tau protein aggregation, or a combination of these and
other factors (Fig. 8B and C).
Our observation that closed-head impact injury also disrupts prefrontal cortical projection neuron synaptic plasticity suggests that acute neurotrauma may interfere with
N-methyl D-aspartate glutamate receptor activation, intracellular second messengers, gene expression, protein synthesis, and/or post-translational modiﬁcations that are
required for LTP-dependent memory mechanisms (Sweatt
et al., 2016). Aberrant neurophysiological responses in
the hippocampal-prefrontal cortex network (Xu and
Südhof, 2013; Sigurdsson and Duvarci, 2015; Place et al.,
2016) are plausible substrates for cognitive, affective, attentional, and executive disturbances associated with post-concussive syndrome (Evans, 2006), traumatic encephalopathy
syndrome (Montenigro et al., 2014), and post-traumatic
stress disorder (Mahan and Ressler, 2012). Bilateral electrophysiological deﬁcits detected in our study are notable
for the anatomical distance of the hippocampus and medial
prefrontal cortex from the primary locus of injury pathology. In our previous blast TBI study (Goldstein et al.,
2012) we observed similar impairments in hippocampal
axonal conduction velocity and hippocampal LTP.
Intriguingly, we detected ultrastructural evidence of persistent microvascular injury in both the hippocampus and
medial prefrontal cortex. Recent evidence also indicates
that neurophysiological deﬁcits, including impaired LTP
in vitro and memory dysfunction in vivo, may be precipitated by pathogenic accumulation of phosphorylated tau
protein (Sydow et al., 2011; Kondo et al., 2015; Fá
et al., 2016). The relationship of tau proteinopathy to
post-traumatic neurophysiological sequelae awaits further
investigation.
Experimental closed-head impact injury in this study
involved contact with the temporomandibular region of
the head and force loading across the zygomatic arch of
the skull. In the mouse, the zygomatic process and squasmosal converge over the lateral perirhinal cortex. Gross
pathology observed in impact-injured mice comports with
classical coup injury biomechanics as documented in analogous brain pathology after impact injuries in humans
(Graham et al., 2002; Blennow et al., 2012; Johnson
et al., 2013b; Jordan, 2013; Leestma and Thibault, 2014;
Kenney et al., 2016; Sharp et al., 2016; Ghajari et al.,
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Figure 8 Model of traumatic microvascular injury, blood–brain barrier disruption, microglial activation, perivascular neuroinflammation, myelinated axonopathy, and phosphorylated tauopathy after closed-head impact injury. (A) Brain capillary with
intact blood–brain barrier and neurovascular unit. The contents within the capillary lumen include blood plasma, blood proteins (including serum
albumin, salb) and formed elements (red blood cells, rbc; circulating monocytes, mono; other white blood cells and platelets, not shown). The
capillary luminal wall is a structurally continuous sheath formed by endothelial cell membranes that are joined at intercellular clefts by tight
junction complexes (tjc). The basal lamina separates endothelial cells from pericytes, multifunctional mural cells that support microvascular and
neurovascular unit function. Astrocyte endfeet ensheath the abluminal capillary wall. The neurovascular unit comprises endothelial cells, astrocytes, pericytes, neurons, and extracellular matrix components that regulate blood–brain barrier function, gas exchange, and bidirectional transit
of fluid, metabolites, nutrients, and signalling molecules between the blood and brain. (B) Injured brain capillary after neurotrauma. (1)
Intraparenchymal shearing forces initiated by focal mechanical injury disrupt local microvascular structure and blood–brain barrier functional
integrity. (2) Compensatory changes in the extracellular matrix, elaboration and expansion of the basal lamina, formation of stress granules,
inclusion bodies, and autophagosomic vacuoles are indicative of traumatic microvascular injury and post-traumatic repair and remodelling. (3)
Astrocytic endfoot engorgement (astrocytic hydrops), organelle degradation (autophagy, mitophagy), and vacuolization are prominent ultrastructural features of capillaries damaged by neurotrauma. Perivascular astrocytes assume a reactive phenotype with concomitant loss of endfoot
organellar integrity and secondary fluid accumulation (presumably from vascular fluid transit and pump failure or endfoot membrane loss).
Together these processes lead to loss of cellular polarity and astrocyte endfoot retraction (involution) along the abluminal capillary wall. (4)
Post-traumatic alterations in microvascular structure further compromise blood–brain barrier integrity and promote extravasation of proinflammatory plasma proteins (e.g. serum albumin, salb) into the brain parenchyma. Damaged capillaries may also facilitate inflammatory cell
diapedesis and red blood cell transit (microhaemorrhage) into the brain parenchymal. (5) Serum albumin and other blood proteins (e.g.
fibrinogen) are highly stimulatory to astrocytes, microglia, and CNS-resident macrophage and drive cellular transformation from resting to
reactive phenotypes. These and other molecular triggers induce local activation and phenotypic transformation of brain-resident microglia,
including increased expression of the triggering receptor expressed on myeloid cells 2 (TREM2), an innate immune receptor expressed on the
surface of activated microglia. Microglial TREM2 expression may be accompanied by endoproteolytic cleavage of the TREM2 ectodomain and
shedding of the resulting cleavage product (sTREM2). Our results indicate that post-traumatic microglial activation and phenotypic transformation
precede infiltration and accumulation of peripheral inflammatory cells at sites of focal brain injury. Localized clusters of hemosiderin-laden
macrophage represent chronic residua of prior microhaemorrhage. (6) Secondary changes in neurons triggered by neurotrauma lead to axonopathy (e.g. demyelination, blebbing, axonal transport dysfunction, phosphorylated tau protein aggregation), dendritic denuding, hyperexcitability,
synaptic dysfunction, and neurodegeneration. (7) Tau protein dissociates from microtubules, undergoes pathogenic phosphorylation (p-tau),
aggregates abnormally within axons, and stimulates pathogenic transport to and miscompartmentalization within the soma and dendrites of
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2017). Virtually all mice subjected to experimental impact
in this study demonstrated transient neurobehavioural deficits that bear striking resemblance to the spectrum of concussion-related responses in humans. By contrast, and to
our surprise, mice exposed to blast under conditions
matched for head kinematics did not exhibit acute neurobehavioural deﬁcits post-injury (Goldstein et al., 2012).
This unexpected observation argues against the concept
that kinematic variables are primary determinants of concussive phenomena (Denny-Brown and Russell, 1941;
Shaw, 2002). Rather, our experimental and computational
results suggest that the observed acute neurobehavioural
responses to closed-head impact injury are triggered by
force point loading and intraparenchymal shear stress foci
in the cerebral cortex that occur before onset of gross head
motion.
These observations are consistent with the following postulated mechanistic sequence based on reported experimental ﬁndings. Cortical shear stresses triggered by impact elicit
rapid neuronal membrane depolarization, massive glutamate release, and metabolic dyshomeostasis (Faden et al.,
1989; Katayama et al., 1990; Yoshino et al., 1991) in cerebral cortex ipsilateral to injury. Released glutamate activates excitatory amino acids receptors that elicit further
depolarization by altering Na + and Ca2 + gating properties
and opening voltage-sensitive ion channels that amplify
transmembrane cation ﬂuxes (Hemphill et al., 2015).
These responses interfere with synaptic neurotransmission,
thereby inducing transient loss of contralateral motor
strength, tone, and coordination as well as impairing vegetative brain functions controlling attention, arousal, and
affect. Neurophysiological function is restored following
neurotransmitter reuptake and synaptic recovery, consistent
with our observations of abrupt onset and rapid recovery
of neurobehavioural deﬁcits post-injury. Mechanical membrane deformation can directly open stretch-sensitive channels that produce aberrant ion ﬂuxes (Hemphill et al.,
2015) and intracellular Ca2 + dyshomeostasis (Gurkoff
et al., 2012; Barkhoudarian et al., 2016). Sudden changes
in local ion concentrations can trigger spreading depolarization (Dreier, 2011; Lippmann et al., 2017) and posttraumatic seizure (Annegers et al., 1998). While post-traumatic seizure was rare in our animal experiments (51% of
impact-injured mice), when present these events invariably
evolved as a classical Jacksonian march noted ﬁrst on the

C. A. Tagge et al.

right side contralateral to left-sided impact with progression
to generalized tonic-clonic seizure followed by post-ictal
immobility. This pattern is consistent with a left-sided
motor cortex seizure focus. Taken together, our results indicate that the transient neurobehavioural impairments triggered by impact result from disruption of cortical function
rather than damage to cortical structures, and as such,
agree with neuronal excitation theories of concussion
(Denny-Brown and Russell, 1941; Walker et al., 1944;
Shaw, 2002).
Interactions between the functional and structural effects
of neurotrauma are complex, dynamic, bidirectional, and
dependent on a variety of injury-related factors, including
type, rate, intensity, geometry, location, and biomechanics
of the inciting insult. Speciﬁcally, we found that different
types of neurotrauma produce varying levels of concussive
functional effects. Furthermore, we observed wide variation
in acute neurological responses within a single mode of
head injury (i.e. impact) (Fig. 2E and F). Moreover, we
found that variation in acute functional responses in our
experimental animal model did not correlate with any of
the measured quantitative indices that we used to assess
brain injury and CTE-related sequelae (Supplementary
Table 3). We interpret these ﬁndings as evidence supporting
interactive linkage rather than dissociation between functional and structural consequences of neurotrauma. This
point is underscored by the fact that functional effects of
head injury, including neurophysiological responses underpinning concussion, are capable of potentiating structural
changes and secondary alterations that lead to further brain
injury and neurological sequelae. For example, sudden release of glutamate in the brain, intracellular calcium dysregulation, and spreading depolarization triggered by
neurotrauma are all known precipitants of metabolic dyshomeostasis, neurotoxicity, neuronal dysfunction, and neurodegeneration (Dreier et al., 2006; Lau and Tymianski,
2010; Dreier, 2011; Hartings et al., 2011; Prins et al.,
2013; Giza and Hovda, 2014; Pietrobon and Moskowitz,
2014; Lewerenz and Maher, 2015; Østergaard et al., 2015;
Barkhoudarian et al., 2016; Rogers et al., 2017). From this
perspective, concussion can be viewed as an observable
clinical manifestation that reﬂects a spectrum of altered
neurological functional states that may or may not be associated with antecedent structural brain injury. Moreover, the
neurobiological conditions underpinning these concussive

Figure 8 Continued
traumatized neurons. (8) P-tau also accumulates in activated microglia, reactive astrocytes, and possibly other brain cells. P-tau propagation and
spread may proceed via extracellular, paracellular, transcellular, and/or glympathic mechanisms. (C) Schematic representation of the axonal
compartment of a healthy neuron (left) and traumatized neuron (right). In healthy neurons, tau protein associates with and stabilizes microtubules
in axons and dendrites. In traumatized neurons, tau protein dissociates from microtubules and undergoes aberrant phosphorylation. P-tau is
prone to pathogenic oligomerization, aggregation, and accumulation within axons, terminals, dendrites, spines, and soma of affected neurons.
Miscompartmentalization of abnormally processed phosphorylated tau promotes release and transmission of p-tau species that contribute to
progressive neurotoxicity and neurodegeneration. (D) Internal force lines (red) show increased stress concentration at structural dishomogeneities in the brain. Anatomical features such as capillaries (cap), depths of cortical sulci, and grey-white matter interfaces are subject to shear
stress amplification (stress concentration) and focal mechanical trauma (arrows). See text for details and discussion.
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states may, ipso facto, alter ongoing metabolic, homeostatic,
cellular, and electrophysiological responses, thereby modulating post-traumatic brain function and neurological
sequelae.
We note several unexpected ﬁndings pertinent to the origins of concussion and relationships to TBI and CTE. First,
we did not detect a correlation between impact intensity
(sled velocity) and acute neurobehavioural responses to
mild closed-head impact injury. Second, acute responses
to experimental impact injury did not correlate with TBI
and CTE endpoints. Speciﬁcally, composite scores on the
test battery did not correlate with quantitative endpoints of
blood–brain barrier disruption, neuroinﬂammation, neurophysiological defects, or phosphorylated tauopathy. Finally,
we observed dissociation between the mechanism of experimental neurotrauma (impact versus blast) and induction of
acute neurobehavioural deﬁcits. Mice subjected to impact
injury reliably demonstrated transient concussion-like impairments, whereas mice exposed to blast with comparable
head motion did not.
Computational simulations revealed dramatic differences
in the evolution of shear stress in the head and brain during
impact compared to blast. Speciﬁcally, our results point to
differences in shear (von Mises) stress as the primary driver
of acute neurobehavioural impairments triggered by impact
injury. Indeed, we found 7-fold larger intracerebral shear
(von Mises) stress during impact compared to blast under
conditions matched for head kinematics. The differences in
intracerebral shear stress (and differential propensity for
acute impairments) derived from distinct loading conditions
in the two types of neurotrauma. For blast, airﬂow around
the skull produces relatively uniform pressure on the head
(Fig. 7F) that does not generate signiﬁcant shear stress in
the brain. By contrast, impact produces focally-concentrated point loading at the impact site. Non-uniform
point loading on the head creates signiﬁcant shear stress
in the brain that persists in a focal region of the brain
ipsilateral and subjacent to the impact contact zone. Focal
shear persistence results from extremely low shear wave
velocity in the brain (Fig. 7G). Intracerebral shear stresses
predicted by impact simulation is in the order of hundreds
of Pascals, a value well above reported thresholds for disruption of brain cell homeostasis (Ravin et al., 2012;
Maneshi et al., 2015). Our results suggest that traumainduced disturbances in brain function may occur in the
absence of overt structural brain pathology. While focal
shear stresses in the brain may be important for production of concussion-like neurobehavioural responses in an
animal model of closed-head impact injury, the neurological consequences of this biomechanical perturbation
may not be limited to acute brain dysfunction. Rather,
our data suggest that exposure to focal shear stress may
also be associated with structural brain injury and its
aftermath.
The differential biomechanical effects of impact and blast
suggest possible substrates and mechanisms that underpin
and link concussion, TBI, and sequelae. While experimental
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impact injury and blast exposure both trigger TBI and
early CTE brain pathologies, only impact induced acute
concussion-like neurobehavioural deﬁcits. Computational
simulations showed that impact induced point loading on
the head and asymmetric shear stress in the brain, whereas
blast exposure, under conditions matched for head kinematics, led to diffuse loading with 7-fold lower intracerebral shear stress. Our results indicate that the primary
biomechanical determinant driving impact-induced acute
neurological deﬁcits is focally-concentrated shear stress
that arises in the cerebral cortex before onset of gross
head motion. By contrast, structural brain injury, focal
pathologies, and functional sequelae correlate with
slower-acting inertial forces associated with head motion
(Holbourn, 1943; Goldstein et al., 2012; Ghajari et al.,
2017).
Shear stress within the brain is subject to localized
ampliﬁcation (stress concentration) due to structural anisotropy and inhomogeneities (Ommaya and Gennarelli,
1974; Gennarelli et al., 1993; Cloots et al., 2008;
Ghajari et al., 2017). Speciﬁc anatomical features that
contribute to stress concentration (e.g. depths of cortical
sulci, grey–white matter interfaces, microvascular-brain
parenchyma junctures; Fig. 8D) also represent brain structures that exhibit the greatest burden of TBI- and CTErelated neuropathology (McKee et al., 2016; Ghajari
et al., 2017; Holleran et al., 2017). These same structures
are also vulnerable to repeated injury, especially if subsequent neurotrauma is sustained during brain recovery
(Laurer et al., 2001; Prins et al., 2013). Prior brain
injury is well known to increase risk of subsequent
injury, slower recovery, poorer outcomes, and in rare
cases, second impact syndrome (Cantu, 1998;
Guskiewicz et al., 2003; Evans, 2006; Mannix et al.,
2013; Terwilliger et al., 2016).
Limitations of the animal experiments include use of
young adult male C57BL/6 mice subjected to a singlerepeat unilateral impact at one injury intensity and evaluated exclusively in the acute-subacute period post-injury
(with exception of cis-p-tauopathy that was evaluated 5.5
months post-injury). While comparing murine and human
ages is fraught with complications (Spear, 2004; Flurkey
et al., 2007), the selected age range represents an informed
choice that balances age as a function of longevity
(Hedrich, 2012), maturational comparability to the
human cases and previous studies (Goldstein et al., 2012;
Kondo et al., 2015), cervical and facial muscle development, skull thickness, and brain development (Kobayashi
et al., 1963; Flurkey et al., 2007; Counotte et al., 2010;
Hedrich, 2012; Smith et al., 2017). Importantly, white
matter microglia reached adult distribution and phenotype
at the selected mouse age, a factor of particular signiﬁcance
for the neuroinﬂammation analyses. The selected murine
age range is consistent with sexual maturity, attainment
of adult body weight and skull thickness, and completion
of major brain development milestones. By these metrics,
mice in this study were roughly comparable in age to the
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human cases. Interpretation and generalizability of our
animal experiments are constrained by animal subject
homogeneity (strain, genotype, age, and sex) as well as
species differences in physiology, metabolism, and anatomy
(skull deformability, spine stability, cervical range of
motion).
Another limitation of the animal model centres on the
deﬁnition of concussion (Angoa-Pérez et al., 2014; Semple
et al., 2015; Giza et al., 2017; McCrory et al., 2017;
Wojnarowicz et al., 2017). Our working deﬁnition of concussion is based on observable neurobehavioural signs that
are primarily, but not exclusively, related to neuromotor
function. Impaired balance and gait are considered part
of the constellation of signs associated with sports-related
concussion (McCrory et al., 2017), and accordingly, were
rigorously evaluated in this study. However, other prominent clinical features of concussion—cognitive impairment,
amnestic deﬁcits, disorientation, slowed reaction time,
headache, emotional lability, alterations in consciousness,
somnolence and sleep disturbances—were not amenable
to experimental evaluation using the current version of
the acute neurobehavioural response test battery. These
limitations warrant caution with respect to generalizing experimental ﬁndings in laboratory animals to clinical conditions in humans. Future studies will beneﬁt from inclusion
of test battery components that are sensitive to speciﬁc alterations in cognitive, affective, and behavioural domains
that are affected by concussion in humans.
Additional limitations apply to the computational simulations. We considered effects on and within a computationally simpliﬁed headform, while neglecting contributions
of neck and torso tethering to the body. However, with
respect to the calculated timescales of interest, we observed
pronounced shear stresses prior to onset of gross head
motion when tethering effects would not be signiﬁcant.
We also assumed a simpliﬁed spherical head with concentric material layers of skull and CSF without dura or soft
tissues, as well as isotropic brain composition without internal structure. We note that a more complex anatomical
description would not have changed the conclusions
deduced from the simulations. In addition, we only considered a single set of initial conditions for the impact
and blast simulations. Future studies in which the magnitude of shear forces within a single model is systematically
varied may yield additional information germane to establishing causal links between loading conditions during
injury and its aftermath. Moreover, the temporal relationships between initiation and propagation of shear stress
foci in the brain and onset of acute neurological responses
remain to be empirically validated in vivo. Despite these
caveats, the computational simulations closely agreed with
experimental head kinematics and support mechanistic explanations that comport with simple biomechanical principles and clinical observations.
Based on this evidence, we conclude that the mechanisms
underpinning the transient concussion-like deﬁcits observed
in mice after experimental closed-head impact are triggered
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by fast-acting, high-amplitude shear stress ﬁelds that arise
in the cerebral cortex before onset of gross head motion.
Our results also suggest that concussion, TBI, and CTE
represent distinct nosological entities subserved by different
pathobiological mechanisms. Speciﬁcally, our ﬁndings indicate that closed-head impact injury, independent of concussion, represents a potent insult with potential to induce
enduring neurophysiological dysfunction and persistent
(and possibly progressive) sequelae, including CTE brain
pathology. Furthermore, our ﬁndings from blast and
impact support the concept that disparate types of neurotrauma with distinct injury mechanisms and differing potential for concussion can trigger convergent brain
pathologies and functional sequelae.
Collectively, these results raise concern that repetitive
neurotrauma, independent of concussion, may induce
early CTE brain pathologies, even in teenagers and young
adults. Cumulative exposure to such injuries may also increase risk for other tau protein neurodegenerative diseases,
including Alzheimer’s disease (Stein et al., 2015b). These
considerations are important not only for understanding
and differentiating concussion, TBI, and CTE, but also to
inform clinical practice, return-to-play protocols, and
public health policy.
This study also raises many questions. How much tau
pathology is clinically signiﬁcant? What is the relationship
of speciﬁc tau species and other molecular and cellular
pathologies to latent brain disease and chronic sequelae
triggered by brain injury? How do pathogenic tau proteoforms propagate through the brain and can this process be
prevented or reversed? Which clinical biomarkers are best
suited for diagnostic detection, endophenotype differentiation, prognostic stratiﬁcation, and longitudinal monitoring
of TBI and CTE? Animal models that recapitulate clinical
features of concussion, TBI, and CTE provide a powerful
platform to address these issues. We anticipate that answers
to these questions will facilitate development of new diagnostics, therapeutics, protective equipment, and preventive
measures for acute and chronic effects of impact
neurotrauma.

Acknowledgements
The authors gratefully acknowledge the use of resources
and facilities at and support from the Edith Nourse
Rogers Memorial Veterans Hospital (Bedford, MA, USA),
Boston VA Healthcare System (Jamaica Plain, MA, USA),
Boston University School of Medicine (Boston, MA, USA),
and Boston University Alzheimer’s Disease Center, CTE
Program (Boston, MA, USA). We thank Tom Balon,
Ph.D., Director, Boston University Metabolic Phenotyping
and In Vivo Imaging Core, for assistance with the IVIS
imaging system (NIH-NCRR, S10RR024523). The authors
gratefully acknowledge resource support from Thermo
Scientiﬁc (Waltham, MA), Tech Imaging (Saugus, MA),
Teledyne CETAC Technologies (Omaha, NE), and Ofﬁce

Early CTE brain pathology after closed-head impact injury

of the Dean, Boston University School of Medicine. Work
by W.C.M. and A.T.A. was performed under the auspices
of the U.S. Department of Energy by Lawrence Livermore
National
Laboratory
under
Contract
DE-AC5207NA27344. Work by W.C.M. was performed, in part,
while a Consulting Professor in the Department of
Structural Biology, Stanford University School of
Medicine. The authors also gratefully acknowledge the individuals and families whose participation and contributions made this work possible.

Funding
NIH F31NS077796 (C.A.T.), NIH 5T32EB006359
(C.A.T.), NIH 1F31NS080564 (A.G.B.), University of
California, Berkeley Bakar Fellowship (D.K.). NIH
R01AG029385 (K.P.L.), NIH R01NS32151 (R.M.R.),
NIH R01NS044421 (P.K.S.), NIH-NIA Boston University
Alzheimer’s Disease Center P30AG13846 and supplement
0572063345 (N.W.K.), NIH-NIA Boston University
Framingham Heart Study R01AG1649, NIH-NINDS
1UO1NS086659 (A.C.M.); U.S. Department of Veterans
Affairs Veterans Affairs Biorepository CSP 501 (A.C.M.),
Veterans Health Administration Clinical Sciences Research
and Development Merit Award I01-CX001038 (T.D.S.);
U.S. Department of Defense W81XWH-13-2-0064 and
VA I01 RX 002170 (A.C.M.); Peer Reviewed Alzheimer’s
Research Program (DoD-PRARP) 13267017 (A.C.M.),
DoD-PRARP
W81XWH1310263
(L.E.G.);
U.S.
Department of Energy contract to Lawrence Livermore
National Laboratory DE-AC52-07NA27344 (A.T.A.,
W.C.M.). Alzheimer’s Association NIRG-305779 (T.D.S.),
European
Union
Seventh
Framework
Program
EPITARGET 602102 (A.F.), Israel Science Foundation
(A.F.), Canadian Institute of Health Research (A.F.),
National Operating Committee on Standards for Athletic
Equipment (A.C.M.), The Linden Fund (P.K.S.) Concussion
Legacy Foundation (A.C.M., L.E.G.), WWE (A.C.M.,
L.E.G.); unrestricted gifts from the Andlinger Foundation
(A.C.M.), WWE (A.C.M.), National Football League
(A.C.M.); Crown Family for support of the US-Israel TBI
Collaborative Research Program (A.F., L.E.G.).
The views and opinions of authors V.E.A., B.R.H.,
N.W.K., T.D.S., and A.C.M. expressed herein should not
to be construed as ofﬁcial positions of the Department of
Veterans Affairs or the U.S. government.

Conflict of interest
K.P.L. and X.Z.Z. are inventors of Pin1 technology, which
is licensed by Beth Israel Deaconess Medical Center
(BIDMC) to Pinteon Therapeutics, Inc. (Concord, MA).
K.P.L. and X.Z.Z. are equity holders and consult for
Pinteon. Their interests were reviewed and managed by
BIDMC in accordance with its conﬂict of interest policy.

BRAIN 2018: 141; 422–458

| 453

R.M.R. is an employee of Biogen and holds company
stock. R.C.C. receives consulting remuneration from
National Football League (NFL), National Operating
Committee on Standards for Athletic Equipment
(NOCSAE), and the Concussion Legacy Foundation.
R.C.C. also receives book royalties. C.J.N. is a salaried
employee of the Concussion Legacy Foundation, a taxexempt nonproﬁt organization. C.J.N. has received
travel reimbursement while serving on advisory boards
for the NFL Players Association, Major League
Lacrosse, WWE, and The Ivy League, is eligible for
book royalties, and receives speaking fees and travel
reimbursement for educational lectures. L.E.G. is a consultant for Rebiscan, Inc.

Supplementary material
Supplementary material is available at Brain online.

References
Abbas K, Shenk TE, Poole VN, Breedlove EL, Leverenz LJ, Nauman
EA, et al. Alteration of default mode network in high school football
athletes due to repetitive subconcussive mild traumatic brain injury:
a resting-state functional magnetic resonance imaging study. Brain
Connect 2015; 5: 91–101.
Adams JH, Graham DI, Murray LS, Scott G. Diffuse axonal injury due
to nonmissile head injury in humans: an analysis of 45 cases. Ann
Neurol 1982; 12: 557–63.
Alosco M, Kasimis A, Stamm J, Chua A, Baugh C, Daneshvar D, et al.
Age of ﬁrst exposure to American football and long-term neuropsychiatric and cognitive outcomes. Transl Psychiatry 2017; 7:
e1236.
Angoa PM, Kane MJ, Briggs DI, Herrera MN, Viano DC, Kuhn DM.
Animal models of sports-related head injury: bridging the gap between preclinical research and clinical reality. J Neurochem 2014;
129: 916–31.
Annegers JF, Hauser WA, Coan SP, Rocca WA. A population-based
study of seizures after traumatic brain injuries. N Eng J Med 1998;
338: 20–4.
Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, et al.
Depletion of microglia and inhibition of exosome synthesis halt tau
propagation. Nat Neurosci 2015; 18: 1584–93.
Atagi Y, Liu C-C, Painter MM, Chen X-F, Verbeeck C, Zheng H,
et al. Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2). J Biol Chem 2015; 290:
26043–50.
Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, et al.
Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007; 317: 666–70.
Bar-Klein G, Cacheaux LP, Kamintsky L, Prager O, Weissberg I,
Schoknecht K, et al. Losartan prevents acquired epilepsy via TGFbeta signaling suppression. Ann Neurol 2014; 75: 864–75.
Barkhoudarian G, Hovda DA, Giza CC. The molecular pathophysiology of concussive brain injury—an update. Phys Med Rehabil Clin
N Am 2016; 27: 373–93.
Barrow DW, Rhoads HT. Blast concussion injury. JAMA 1944; 125:
900–2.
Bazarian JJ, Zhu T, Zhong J, Janigro D, Rozen E, Roberts A, et al.
Persistent, long-term cerebral white matter changes after sportsrelated repetitive head impacts. PLoS One 2014; 9: e94734.

454

| BRAIN 2018: 141; 422–458

Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, et al.
Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 2010; 68:
409–27.
Bhaskar K, Konerth M, Kokiko-Cochran ON, Cardona A, Ransohoff
RM, Lamb BT. Regulation of tau pathology by the microglial fractalkine receptor. Neuron 2010; 68: 19–31.
Bieniek KF, Ross OA, Cormier KA, Walton RL, Soto-Ortolaza A,
Johnston AE, et al. Chronic traumatic encephalopathy pathology
in a neurodegenerative disorders brain bank. Acta Neuropathol
2015; 130: 877–89.
Blennow K, Hardy J, Zetterberg H. The neuropathology and neurobiology of traumatic brain injury. Neuron 2012; 76: 886–99.
Blumbergs PC, Scott G, Manavis J, Wainwright H, Simpson DA,
McLean AJ. Staining of amyloid precursor protein to study axonal
damage in mild head injury. Lancet 1994; 344: 1055–6.
Breedlove EL, Robinson M, Talavage TM, Morigaki KE, Yoruk U,
O’Keefe K, et al. Biomechanical correlates of symptomatic and
asymptomatic neurophysiological impairment in high school football. J Biomech 2012; 45: 1265–72.
Broglio SP, Schnebel B, Sosnoff JJ, Shin S, Fend X, He X, et al.
Biomechanical properties of concussions in high school football.
Med Sci Sports Exer 2010; 42: 2064–71.
Brooks SP, Dunnett SB. Tests to assess motor phenotype in mice: a
user’s guide. Nat Rev Neurosci 2009; 10: 519–29.
Cantu RC. Second-impact syndrome. Clin Sports Med 1998; 17:
37–44.
Carroll LJ, Cassidy JD, Holm L, Kraus J, Coronado VG.
Methodological issues and research recommendations for mild traumatic brain injury: the WHO Collaborating Centre Task Force on
Mild Traumatic Brain Injury. J Rehabil Med 2004 (43 Suppl):
113–25.
Cherry JD, Tripodis Y, Alvarez VE, Huber B, Kiernan PT, Daneshvar
DH, et al. Microglial neuroinﬂammation contributes to tau accumulation in chronic traumatic encephalopathy. Acta Neuropathol
Commun 2016; 4: 112.
Cheslow L, Alvarez JI. Glial-endothelial crosstalk regulates blood–
brain barrier function. Curr Opin Pharmacol 2016; 26: 39–46.
Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S,
Probst A, et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 2009; 11: 909.
Cloots RJ, Gervaise HM, van Dommelen JA, Geers MG. Biomechanics
of traumatic brain injury: inﬂuences of the morphologic
heterogeneities of the cerebral cortex. Ann Biomed Eng 2008; 36:
1203–15.
Counotte DS, Li KW, Wortel J, Gouwenberg Y, Van Der Schors RC,
Smit AB, et al. Changes in molecular composition of rat medial
prefrontal cortex synapses during adolescent development. Eur J
Neurosci 2010; 32: 1452–60.
Crawley JN. Behavioral phenotyping of transgenic and knockout mice:
experimental design and evaluation of general health, sensory functions, motor abilities, and speciﬁc behavioral tests. Brain Res 1999;
835: 18–26.
Crisco JJ, Fiore R, Beckwith JG, Chu JJ, Brolinson PG, Duma S, et al.
Frequency and location of head impact exposures in individual collegiate football players. J Athletic Train 2010; 45: 549–59.
Crisco JJ, Wilcox BJ, Beckwith JG, Chu JJ, Duhaime AC, Rowson S,
et al. Head impact exposure in collegiate football players. J Biomech
2011; 44: 2673–8.
Critchley M. Punch-drunk syndromes: the chronic traumatic encephalopathy of boxers. In: Neurochirurgie: hommage a clovis vincent.
Paris, France: Maloine; 1949.
Critchley M. Medical aspects of boxing, particularly from a neurological standpoint. BMJ 1957; 1: 357.
Davenport EM, Whitlow CT, Urban JE, Espeland MA, Jung Y,
Rosenbaum DA, et al. Abnormal white matter integrity related to

C. A. Tagge et al.
head impact exposure in a season of high school varsity football.
J Neurotrauma 2014; 31: 1617–24.
David Y, Cacheaux LP, Ivens S, Lapilover E, Heinemann U, Kaufer D,
et al. Astrocytic dysfunction in epileptogenesis: consequence of
altered potassium and glutamate homeostasis? J Neurosci 2009;
29: 10588–99.
De Beaumont L, Tremblay S, Henry LC, Poirier J, Lassonde M,
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